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Abstract 
 
Structural biology is a branch of science related to biochemistry, biophysics, and molecular 
biology that deals with the molecular structures of biological macromolecules, in particular 
nucleic acids and proteins.  Structure-guided drug design uses three-dimensional 
knowledge of protein structures to design small molecules which block the action of 
specific proteins.   When crystals of theses macromolecules and their complexes can be 
obtained, their crystal structures can be determined by using isomorphous differences 
between a native structure and a derivative structure.  This allows crystallographers to 
determine the coordinates of a small number of heavy atoms which provide initial phases 
for macromolecules.  The advent of synchrotron radiation allowed determination of a 
heavy atom substructure by use of anomalous differences using either multiple 
wavelengths (MAD) or a single wavelength (SAD); the latter has become the most common 
phasing method in crystallography and is the method used in this study.  The use of SeMet 
has been by far the most successful method employed in SAD.  However, in some cases 
production of SeMet proteins is not possible thus necessitating additional options, for 
example, xenon. 
Noble gases such as xenon may be used in SAD experiments by binding to various, non-
specific sites.  Advances in noble gas pressurization systems like the Hampton Research 
Xenon Chamber have greatly eased the production of noble gas derivatives, xenon itself 
being a prime candidate with a very strong anomalous signal when compared to lighter 
noble gases like krypton and argon.  Investigation of the phasing properties of xenon was 
carried out on test proteins hen egg white lysozyme (HEWL), thermolysin, glucose 
isomerase, and thaumatin II.  Phases were successfully determined for all four proteins 
including thaumatin II which did not bind xenon but was successful due to the anomalous 
signal from 17 native sulfurs.  The three remaining proteins showed varying occupancies 
and numbers of sites including xenon sites in thermolysin and glucose isomerase which 
have not been observed previously.  This document will serve as a guide for the 
preparation of xenon derivative crystals and provides a strategy for the collection and 
processing of data from xenon derivatives.   
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1.0 Hypothesis & Objectives 
 
1.1 Hypothesis 
Xenon derivatives produced by xenon gas pressurization can be used in SAD experiments 
for phasing of macromolecules by as few as one partially occupied xenon site. 
 
1.2 Objectives 
1. Develop a reliable, step-by-step procedure which will allow phasing of de novo 
proteins using the anomalous signal from bound xenon atoms.  The procedure 
will include: 
 Gas pressure and pressurization time 
 Data collection strategy 
 Data processing strategy 
2. Test the proposed procedure on a protein which is known to bind xenon. 
 Grow HEWL crystals 
 Derivatize HEWL crystals using Hampton Research Xenon Chamber 
 Collect Data 
 Identify anomalous signal 
 Locate anomalous substructure using anomalous differences and build model 
 Refinement of f’’ values 
 Visual inspection of  xenon sites 
 Compare model with Protein Data Bank (PDB) 
3. Use the procedure for efficient phasing of several other test proteins. 
 Thaumatin II, thermolysin, and glucose isomerase 
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2.0 Introduction 
Macromolecular crystallography is a main method for obtaining high resolution structures 
of macromolecules such as proteins, viruses, nucleic acids (DNA and RNA), and 
carbohydrates.  This high resolution helps in explaining the detailed mechanisms by which 
these macromolecules carry out their functions in living cells and organisms.  This year the 
Protein Data Bank (PDB) has surpassed 100,000 entries with about 80% of these 
structures determined at synchrotrons.  The dominating method for phasing has made use 
of selenomethionine-SAD1.  However, selenomethionine can be toxic and incorporation 
may result in very low expression yields.   
In such cases, or when it is not possible to produce selenomethionine-containing proteins 
or to grow their crystals, an alternative method can be used: sulfur-SAD (S-SAD).  However, 
this method normally requires at least one sulfur per approximately 25 residues in the 
protein sequence2.  Xenon derivatization is a method that would be very beneficial for 
cases when there are not enough sulfurs, but could also be recommended as an addition to 
any S-SAD experiment in order to increase anomalous signal and improve the chances of 
solving the crystal structure. 
 
2.1 Synchrotron Radiation 
Synchrotron radiation is produced when charged particles such as electrons are forced to 
accelerate at relativistic speeds.  Large machines are built to force electrons to travel in a 
circular path at near the speed of light.  This produces a very narrow and intense beam of 
polychromatic radiation.  The use of double crystal monochromators (DCM) allows 
researchers to tune synchrotron radiation to a desired monochromatic wavelength.   
Synchrotron radiation is essential to modern protein x-ray crystallography whereby very 
weak anomalous signals originating from anomalously scattering atoms are measured and 
exploited.  Choosing the proper wavelength is important for maximizing anomalous signal.   
Furthermore, the high intensity of synchrotron radiation allows data collection in a fraction 
of the time required with conventional x-ray sources3.   
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3rd generation synchrotron facilities such as the Canadian Light Source (CLS) provide 
further improvement in radiation intensity allowing for even faster data collection.  This 
generation of synchrotrons is made possible with the advent of insertion devices called 
wigglers and undulators.  An insertion device is a periodic magnetic structure which causes 
electrons to travel in a sinusoidal path as they pass through the device gap; the result of 
this motion is an increase in brilliance.  Undulators are specially tuned to produce 
constructive interference between electrons resulting in a narrow radiation bandwidth 
with an increase in brilliance superior to wigglers3. 
 
2.1.1 CLS 
The Canadian Light Source located in Saskatoon, Saskatchewan at the University of 
Saskatchewan is Canada’s national synchrotron research facility.  This state of the art 3rd 
generation synchrotron is dedicated to advancing Canadian science and providing 
Canadian industry with a world class facility for conducting academic and industrial 
research.  The staff of the Canadian Macromolecular Crystallography Facility operates  two 
crystallography beamlines CMCF-ID (08ID-1) and CMCF-BM (08B1-1) providing on site, 
mail-in, and remote data collection services4. 
 
2.2 Methods of Protein Crystallography 
Protein crystallography takes advantage of the fact that proteins grow into crystals under 
certain conditions.  These protein crystals are made up of regular, repeating copies of the 
simplest unit called the asymmetric unit (ASU); several copies of the ASU may be present in 
the unit cell.  Unit cells may be arranged into fourteen Bravais lattices and when combined 
with all 32 point groups, there are 230 possible space groups when translational symmetry 
is considered.  Of the 230 possible space groups, only those which preserve chirality are 
valid which reduces the number of possibilities to 655.   
The ordered, repeating nature of crystals results in both diffraction and amplification of 
scattered x-rays.  The tiny fraction of x-ray diffraction coming from each copy of the ASU is 
amplified by the number of copies in the crystal.  The resulting signal is sampled onto 
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discrete points and is large enough to measure.  Synchrotron radiation is almost always 
preferable due to high intensity and high collimation both of which allow shorter exposure 
times and quicker experiments with increased accuracy.  Synchrotron radiation also has 
the advantage of being tuneable.  This allows the energy at which experiments are carried 
out to be changed as in the case of SAD/MAD experiments. 
 
2.2.1 X-ray Diffraction 
X-rays in the energy range appropriate for diffraction experiments interact with matter 
through their electrons.  The atom’s electrons first absorb the x-ray energy and then act as 
an elastic point source by re-emitting x-rays without changing their energy.  This happens 
with each and every atom in the crystal producing wave interference; essentially, protein 
crystals are three-dimensional diffraction gratings for electromagnetic radiation in the x-
ray range5.  Wave interference manifests as a diffraction pattern of constructive x-ray 
reflections and represents a snapshot of the protein in reciprocal space.  If enough 
snapshots are taken and reflections measured, the electron density of the atoms which 
produced the diffraction patterns may be reconstructed5. 
A crystal can be modeled as a set of parallel planes with constant interplanar distance 
S(hkl).  The indices h, k, and l describe the family of planes which cut the unit cell into h, k, 
and l equal parts e.g. hkl=201 means that this family of planes cuts the unit cell on the x-
axis into 2 pieces each a/2 in length, does not cut the unit cell on the y-axis and so runs 
parallel to the y-axis, and cuts the unit cell along the z-axis into 1 piece of length c5.  For a 
given wavelength, λ, angles of incidence and reflection θ with respect to the planes (Figure 
2.1), and some integer, n=1,2,3,…, it is possible to calculate where constructive interference 
will occur: 
                 (2.1) 
Bragg’s law (2.1) describes the conditions for constructive interference5. 
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Figure 2.1 Definition of the scattering vector S 
The scattering vector S is the difference between the incident beam s0 and the scattered 
beam s1. 
 
 
Every point in the protein electron density, ρ(r), produces a partial wave which is 
described by a wave of the form exp(iφ) with a relative phase of φ=2πS·r and a magnitude 
based on the electron density within the volume element.  After integration over the atomic 
volume, the total resulting wave from an atom is: 
    ∫                  
        
 
 (2.2) 
From equation 2.2, an individual atom’s ability to scatter x-rays is dependent on the 
electron density ρ at r, and on the scattered wave vector, S, which is the difference between 
the incoming and scattered wave vectors s0 and s1, respectively (Figure 2.1).  S is 
dependent on the type of atom doing the scattering and falls off with angle θ as 
|S|=(2sinθ)/λ.  The scattering factor for an entire molecule then is simply the summation of 
the individual scattering factors from each point, r: 
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       ∑               
       
    (2.3) 
where F(S) is a vector in reciprocal space and F(S) → F(hkl) with the scalar product 
             . 
As mentioned earlier, a diffraction image is an image of the protein in reciprocal space.  
Each measured reflection is called a structure factor, F(hkl), and each contains within it all 
of the structural information for a whole family of parallel planes hkl.  As the crystal is 
rotated and images are taken at different orientations, equation 2.3 is satisfied for some 
reflections which begin to interfere constructively while other reflections disappear. It is 
possible to continue in this manner until each reflection has been recorded several times.  
The electron density in direct space is related to the structure factors in reciprocal space by 
a Fourier transform.   
          [      ]   
 
 
∭           [              ]      
   
      
  (2.4) 
In practice, data are not continuous but are instead produced at discrete points and 
equation 2.4 reduces to a triple Fourier summation using the relationship F=|F|e-iα: 
         
 
 
∑             [                      ]          (2.5) 
where V is the volume of the unit cell, |F(hkl)| is the structure factor amplitude arising from 
planes having indices hkl, α(hkl) is the phase, and xyz are the coordinates of the electron 
density, ρ(xyz), in direct space.  In order to calculate the electron density in direct space, 
ρ(xyz), all structure factors must be measured and then applied to all points in space.  
Structure factors with higher indices are more difficult to measure and correspond to more 
closely spaced planes. The closer planes are to one another, the more finely sampled is the 
crystal lattice leading to higher resolution ρ(xyz)5. 
Structure factors can be represented by complex numbers on the complex (Argand) plane 
meaning that they have both amplitude and a phase which must be determined.  Structure 
factor amplitudes are easily measured from diffraction images because diffraction intensity 
is proportional to the square of the structure factor amplitude: 
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 I(hkl) ∝ |F(hkl)|2  (2.6) 
Phases, α(hkl), cannot be measured directly.  Instead, other methods are used to obtain 
phases; this is called the phase problem in crystallography5.   
 
2.2.2 Derivatization 
Derivatization is the process by which phase information is obtained by incorporating one 
or more heavy atoms into a native protein crystal.  The phase problem has long been solved 
using isomorphous differences between a native and one or more derivative data sets.  
Using this method, the positions of the heavy atoms can be approximated using the 
difference between the derivative and native datasets (Figure 2.2).  An extension of the 
isomorphous difference method, and the one used in this study, is to measure the very 
small anomalous differences produced when atoms reveal anomalous x-ray scattering.  
This method relies on the fact that chosen derivative atoms exhibit significant anomalous 
scattering in diffraction experiments while native protein atoms such as carbon and 
nitrogen do not.  More recently, the anomalous signal coming from native sulfur atoms in 
methionine and cysteine residues have provided sufficient anomalous signal to solve 
structures6–8.  Making use of anomalous differences is a much more sensitive experiment 
and is made possible due to advances in protein crystallography, software algorithms, and 
synchrotron techniques.  The current standard for de novo phasing done via SeMet labeled 
protein requires labor-intense additional expression, purification, crystallization steps, and 
data collection whereas derivatization with xenon uses existing native crystals. 
 
8 
 
 
Figure 2.2 Protein derivatization 
Principle of difference method used in protein crystallography to solve the phase problem.  
The experimental phasing relies on isomorphous difference data.  It can originate from 
heavy atoms (SIR, MIR), anomalous differences between Bijovet pairs of the same data set 
(SAD), dispersive and anomalous differences between different wavelengths (MAD), or any 
combination thereof. 
 
 
2.2.2.1 Direct Methods 
Direct methods were initially developed to solve small molecule crystal structures and are 
good for solving structures up to 100 non-hydrogen atoms9.  These methods are 
impractical for determining protein structures themselves but are perfect for determining 
the coordinates of a small heavy atom substructure and consequently the initial phases for 
a protein.  These methods make use of mathematical relationships which exist between 
combinations of phases.  Once a few phases can be given approximate starting values or are 
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known, these relationships can be used to “bootstrap” additional phases to build a 
complete set10,11. 
Direct methods require comparison between reflections.  Since structure factor amplitudes 
fall off with the scattering angle, θ, they must be normalized using the expectation value, 
‹F2›, for that scattering angle: 
    
  
  
 
〈  〉
 (2.7) 
  〈  〉    ∑   
      
       
  
  (2.8) 
where λ is the x-ray wavelength, B is the atomic displacement factor, k is the scale factor, 
and ε is a symmetry enhancement factor.  In the calculation of ‹F2› it is important that all 
reflections are measured in the relevant θ range including the very weak reflections11. 
An important relationship which exists between structure factors was formulated by 
Sayre12 and is based on two assumptions.  The first criterion is that the electron density in a 
structure can never be negative, called positivity, and the second is that atoms are well-
defined points of electron density, called atomicity.  Based on these assumptions, we can 
calculate the structure factor of some hkl reflection as the sum of the products of all pairs of 
reflections whose indices add up to hkl: 
        ∑    
                               (2.9) 
For example, reflection (321): 
                                                     (2.10) 
This relationship may not seem particularly useful but it gives very good approximations 
because any pairs of reflections in 2.10 where one or both reflections are weak can initially 
be ignored.  However, in the case that both structure factors are strong and the structure 
factor being calculated is also strong, then there is a good chance that the structure factor 
being calculated from 2.10 is accurate11.   
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Another relationship called the triplet relationship (2.11) relates the phases and indices of 
3 reflections: 
                                      (2.11) 
For example, reflection (022): 
                          (2.12) 
For a system that is small enough to allow a large percentage of these relationships to be 
examined at once, it is possible to build enough constraints on phases in order to obtain 
fairly good initial estimates.  One more important relationship for relating phases is the 
tangent formula derived by Karle & Hauptman10: 
        
∑                               
∑                               
 (2.13) 
 
2.2.2.2 Patterson Method 
The other method for locating heavy atoms and obtaining initial phases is by use of the 
Patterson function 
         
 
 
∑             [            ]    (2.14) 
where uvw are coordinates in Patterson space which are analogous to atomic coordinates 
xyz except that they correspond to interatomic vector peaks5,11.  This means that some 
peaks are the result of self-vectors and will lie on the origin of the Patterson map.  
Patterson peaks are also centrosymmetric meaning that, given two atoms, the peak arising 
from 2-1 is centrosymmetrically related to the peak arising from 1-2.  For N atoms, the 
Patterson map will contain N origin peaks with N2-N off-origin peaks (Figure 2.3).   
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Figure 2.3 Patterson maps 
Each peak in the Patterson map corresponds to an interatomic vector between atoms in a 
crystal.  An increase in the number of atoms quickly yields a Patterson map which has too 
many peaks to interpret.  
 
 
Due to the large number of peaks, it is not possible to determine the locations of atoms 
directly and this problem becomes much worse as the number of atoms increases.   
However, the Patterson function can still be of use as it is useful for determining the 
locations of a small heavy atoms substructure.  The advantage of using the Patterson 
function is that |F(hkl)| values can be measured directly from diffraction images by relation 
2.6 without any need for phase information5,11,13.   
The intensity of a Patterson peak is estimated as the product of the number of electrons 
that the two atoms have.  In this manner, peaks corresponding to pairs of “light” atoms will 
be less intense than peaks corresponding to heavy atom light atom pairs which will be less 
intense than peaks arising from pairs of heavy atoms.  Knowing this about Patterson maps, 
it is easy to see that the most intense peaks will come as a result of heavy atom 
relationships.  This allows determination of the locations of a few heavy atoms by looking 
at the most intense peaks in the Patterson map.  Harker sections (peaks, lines, and planes) 
are special locations on the Patterson map where peaks arising from symmetry-related 
atoms occur (Figure 2.4).  The difference between an atomic position x,y,z and a symmetry 
related position such as -x,½+y,-z (P21) provides the locations of these Harker sections.  
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Once these sections are found, then the most intense peaks in these sections correspond to 
symmetry-related heavy atoms, the locations of which can be easily determined5,11. 
 
Figure 2.4 Harker vectors, sections 
Patterson peaks occur at the endpoints of vectors between all pairs of atoms in a unit cell of 
the crystal.  Consider one site and its general equivalent positions (g.e.p.’s) related by space 
group symmetry; vectors between these symmetry-related atoms are known as Harker 
vectors.  For space group P21 (21 axis along b), xyz are the site coordinates, and uvw are the 
Patterson coordinates.  In P21 the Harker vector always occurs in the section defined by 
v=1/2 regardless of the site coordinates.  This section v=1/2 in the Patterson for space 
group P21 is a Harker section. 
 
 
2.2.1 SAD (Single-Wavelength Anomalous Dispersion) 
For years researchers have solved the phase problem by soaking native crystals in salt 
solution of heavy atoms or by co-crystallization in order to produce heavy atom 
derivatives.  Historically, the seven most successful compounds have been K2PtCl4, 
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KAu(CN)2, K2HgI4, UO2(C2H3O2), HgCl2, para-chloro mercury benzoic acid sulfonate 
(PCMBS) and K3UO2F5 14 and by producing several different derivatives, phase information 
may be obtained by a process known as Multiple Isomorphous Replacement (MIR).  This 
condition of isomorphism is, in fact, not only a condition for MIR but is required for any 
phasing technique in which some heavy atom is introduced and multiple derivatives are 
required. 
More recently, anomalous difference phasing methods take advantage of the atom’s ability 
to absorb x-rays of certain wavelengths so called absorption edges.  Usually when x-rays 
are diffracted by protein crystals, structure factors amplitudes measured from reflections 
on opposite sides of the same plane are equal: 
  |F(hkl)| = |F(-h-k-l)| (2.15) 
this is known as Friedel’s Law.  When the incident x-ray wavelength approaches an atom’s 
absorption edge, a fraction of the x-rays are absorbed by the atom and then re-emitted with 
altered phase meaning that Friedel’s Law no longer applies5,13.  The total structure factor, F, 
for an anomalously scattering atom is the sum of a wavelength-independent part, f0, and 
the wavelength-dependent real and imaginary parts of the anomalous scatterer: 
  F(λ) = f0 + f ’(λ) + i f ’’(λ)  (2.16) 
where f‘ is the real scattering component which is in phase with f0 and usually negative, and 
f‘’ is the imaginary scattering component which is always π/2 ahead of phase of the real 
parts f0 and f’ 5. These small but measurable differences between Friedel pairs allow 
crystallographers to extract phase information from a single crystal by single-wavelength 
anomalous dispersion (SAD) or by using multiple wavelengths (MAD) if necessary. 
Anomalous dispersion methods work because most of the atoms in proteins are hydrogen, 
oxygen, carbon, and nitrogen which are considered “light” and do not exhibit significant 
anomalous scattering at the wavelengths used in crystallography experiments.  Some 
anomalous scattering atoms occur naturally such as sulfurs from cysteine and methionine 
amino acids or iron from oxygen-carrying proteins.  Other times, proteins may require the 
introduction of anomalous scatterers by methods such as the heavy atom salt soak14, 
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replacement of methionine amino acids by selenium-containing amino acids called 
selenomethionine6,15, iodine soaking which has been found to bind to various, non-specific 
binding sites16,17, or by pressurization of noble gases such as xenon or krypton18.  
None of these methods works 100% of the time, however.  Aside from being somewhat 
harsh, heavy-atom salt soaks will not work if the protein has no binding sites for that 
particular heavy atom.  Replacement of methionine by selenium-containing 
selenomethionine has made selenium by far the most used phasing element15 but even this 
method will not work if the protein contains little or no methionine amino acids.  
Sometimes methionine amino acids or metal binding sites may be incorporated by site-
directed mutagenesis19 but this process involves changing the protein’s native structure 
which may not be desirable.  Having more options for obtaining phase information is 
always beneficial and will aid in avoiding research dead ends due to encountering proteins 
which resist established methods.   
 
2.2.1.1 Optimizing data collection 
The two main aspects required for optimizing SAD data collection are low resolution 
completeness and accuracy (Figure 2.5)20.  Low resolution completeness of reflections from 
20-3.5Å is important because these are the strong reflections which are used in Patterson 
and direct methods to determine initial phases as described earlier21.  The most important 
factors when maximizing data completeness are total rotation range to ensure that each 
reflection is measured as many times as possible and rotation start position which depends 
on crystal orientation and symmetry.  SAD phasing works because of small but measurable 
differences in Friedel pairs; this difference is called the Bijovet ratio, ΔF/F, and is usually on 
the order of only a few percent.  Therefore SAD phasing methods depend very much on 
high accuracy in order to measure these differences.  Accuracy depends on several factors 
the most important of which are high multiplicity, fine slicing which gives better reflection 
profiles, and longer exposure times to minimize the effect of timing errors.  One more key 
consideration is that when obtaining high multiplicity data, images near the end of data 
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collection should be inspected for signs of radiation damage which is detrimental to 
anomalous phasing techniques20,22,23. 
 
 
Figure 2.5  Carrying out an optimal experiment20 
The relative importance of various aspects of data collection for different types of 
crystallography experiments.  Accuracy and low-resolution completeness are very 
important for anomalous phasing experiments.  
 
2.2.2 Cryoprotection 
It is well known that protein crystals may be flash cooled by plunging them into liquid 
nitrogen.  This technique has been used extensively in protein crystallography to transport 
and preserve crystals.   More importantly, the practice of flash cooling protein crystals 
extends the lives of crystals during experiments by reducing the amount of radiation 
damage.  This is especially beneficial when doses are expected to be high as in the case of 
synchrotron radiation or when a high accuracy data set is needed24. 
Solvent channels which exist in all protein crystals may account for more than half of the 
crystal volume.  Upon flash cooling, water molecules in the solvent channels and in solvent 
surrounding the crystal form hexagonal ice which is less dense than water.  This volume 
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expansion is undesirable as it can lead to crystal deformation, destruction of the crystal 
lattice, and even cracking crystals.  Flash cooling crystals and dehydration by removal of 
surrounding water can aid in reducing these negative effects.  The best solution is the use 
of cryoprotectants such as glycerol or PEGs either immediately before flash cooling or as an 
ingredient in the crystallization conditions24. 
 
2.3 Xenon 
Xenon belongs to the category of “heavy atoms” used in protein crystallography.  With 34 
electrons, it is lighter than standard heavy atoms such as mercury, platinum, or uranium.  
Xenon has been known to bind to proteins since the 1950’s25–27 and since then has been 
used to solve structures first using isomorphous differences and more recently using 
anomalous differences28–31.  Xenon derivatives have shown that xenon will bind to many 
different sites including intra- and inter-molecular sites, inaccessible cavities, and exposed 
pockets18.  These sites may also be composed of several types of residues including 
aliphatic, aromatic, and polar residues30.  Xenon has been found to displace water 
molecules that are well defined in native structures but generally prefers hydrophobic 
pockets many of which are buried within the protein and away from the solvent.  These 
sites are distinct from metal-binding sites and are therefore complementary to other 
methods and derivatives18,28.  Furthermore, the occupancy of these binding sites increases 
depending on xenon pressure and an increase in pressure may also increase the number of 
binding sites32.   
Binding happens slowly as gas pressure is applied and xenon diffuses into a crystal through 
solvent channels over a few minutes18,33–35.  Xenon is able to reach buried pockets within 
proteins via solvent channels due to its high solubility in water36–38.   However, xenon 
binding is only possible for as long as an external gas pressure is applied.  This makes 
xenon binding non-covalent and reversible leaving the protein structure wholly unchanged.  
Diffusion of xenon leaving the crystal is also slow.  This is convenient as it allows time to 
release the gas pressure and then “freeze” xenon into crystals using liquid nitrogen33,39,40.   
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Figure 2.6 CSD statistics for xenon binding41 
As a noble gas, xenon does not usually take part in chemical bonding.  There are only 38 
structures in the CSD which involve xenon.  However, there are more than 80 compounds 
known42.  Results of searching the CSD clearly demonstrate two groups of distances.  Those 
less than 2.8Å represent covalent bonds between Xe and O, N, C, F and Cl atoms.  Those 
larger than 3Å are described by 3 types of interactions: charged-induced dipole 
interactions, dipole-induced dipole interactions, and London interactions.   
 
Xenon is a large, neutral atom which, for the most part, is unreactive and does not form 
bonds (Figure 2.6)41,42.  Due to its large size, xenon has a polarizability α =4.00. This is 
relatively high for a single atom especially when compared to lighter noble gases such as 
krypton (α=2.47) and argon (α=1.63).  High polarizability is the result of larger atoms and 
molecules having larger, more dispersed electron densities and is important for the types 
of interactions between noble gases and proteins.   There are three types of interactions43 
which can occur between noble gas atoms and molecular groups in proteins as summarized 
by Schiltz et al.18: 
 
1.5
2
2.5
3
3.5
4
5 7 9 11 13 15 17 19
D
is
ta
n
ce
 t
o
 X
e 
(Å
) 
Atomic Number 
Distance to Xe vs Atomic Number 
C
N
O
F
Cl
18 
 
1. Charge-induced dipole interactions: The induced dipole in the xenon or krypton 
atom is created by an external electric charge.   These interactions could thus 
occur when a charged protein group is located in the vicinity of the noble gas 
atom. 
        
    
  
 (2.17) 
 
The energy for this type of interaction is proportional to the square of the 
electronic polarizability of the noble gas, α, proportional to the square of the 
charge, q, and inversely proportional to the fourth power of the distance 
separating the center of the charge from the center of the noble gas atom, r.  
These are therefore potentially strong interactions (as compared with dipole-
induced and London interactions) and are also active over larger distances.  
2. Dipole-induced dipole interactions: The induced dipole in the xenon or krypton 
atom is created by an external electric dipole.  These interactions occur when 
the noble gas atom is located in the vicinity of polar groups in the protein. 
 
       
   
  
 (2.18) 
 
The binding energy involved in this type of interaction is proportional to the 
square of the magnitude of the dipole moment, µ, proportional to the 
polarizability of the noble gas atom, α, and inversely proportional to the sixth 
power of the distance separating the center of the dipole from the center of the 
gas atom, r.  Hence, it is a truly short-range interaction.   
3. London interactions (also called dispersion interactions): These interactions exist 
between all molecules and atoms, even those that are uncharged and nonpolar.  
They are usually described as arising from the interaction of the instantaneous 
dipoles in both molecules (and atoms).  Each molecule (and atom) possesses 
fluctuating dipoles according to the particular instantaneous distribution of the 
electrons.  These instantaneous dipoles constantly change direction and 
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magnitude, each existing only for a minute fraction of time.  However, the net 
overall interaction between these instantaneous dipoles is an attractive force: 
 
       
    
     
    
  
 (2.19) 
 
where I is the first ionization energy of each molecule.  Once more, the 
interaction energy is proportional to the polarizability of the noble gas atom, α, 
(as well as being proportional to the polarizability of the other interacting atom, 
α) and inversely proportional to the sixth power of the distance separating the 
two atoms, r.  These energies are again weak, usually only a few units of kT, but 
the xenon and krypton atoms in a binding site typically interact with several 
protein atoms, the interaction energies being added up.  The binding of xenon 
and krypton to proteins is dominated by London interactions, mainly because 
the majority of binding sites are formed by nonpolar groups (aliphatic and/or 
aromatic side chains).  But even if there are polar groups in a binding site, it can 
be shown that the London interactions generally contribute to a much larger 
extent to the binding than do the dipole-induced forces18. 
 
In SAD phasing, a strong anomalous signal, f’’, is required.  Xenon’s L-I edge at 5.45keV has 
a very strong anomalous signal f’’=13.4e.  At energies this low, however, x-ray absorption 
due to interactions with air is significant and the anomalous signal is more difficult to 
measure accurately.  That is, it may be lost in the measured data, but is still present in the 
crystal44–47.   But xenon has a very strong anomalous signal even very far from any 
absorption edges e.g. f’’=9.22e @ 7keV (Figure 2.7) which makes it a powerful phasing 
agent.  A caveat is that the strong anomalous signal from a heavy atom such as xenon could 
appear weak due to there being too few binding sites or due to low xenon occupancies.  The 
latter can cause difficulty when attempting to distinguish partially occupied xenon sites 
from other lighter anomalous atoms which also produce an anomalous signal at 7keV 
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(Figure2.8).  Even so, SAD phasing using xenon has been successful using only a single half-
occupied xenon site for proteins as large as 250kDa at 8keV and 650kDa at 5.4keV34.   
The anomalous signal from xenon is similar to iodine which has also been used in SAD 
studies to solve structures48.  The lighter elements of the halogen and noble gas groups 
(Figure 2.9) have also been used to solve structures however their anomalous signal is 
relatively weak when compared to xenon and iodine.  Obtaining sufficient anomalous signal 
from these lighter elements necessitates a large number of binding sites, the use of multiple 
wavelengths near an absorption edge (MAD), or both.  
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Figure 2.7 Theoretical anomalous signal for xenon 
The anomalous signal coming from xenon increases as the x-ray energy is decreased and 
the L absorption edges are approached.  A maximum value of f’’=13.4e is reached at an x-
ray energy of 5.45keV.   Theoretically, data should be collected at an energy slightly above 
this to maximize anomalous signal.  Due to absorption of scattered x-rays by air at such low 
x-ray energies, a higher energy must be chosen to compromise between x-ray absorption 
and anomalous signal from xenon. 
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Figure 2.8 Theoretical anomalous signal for xenon and common atoms 
There are many naturally occurring atoms in protein crystals, including atoms which are 
added during purification and crystallization, which contribute to anomalous signal at 
7keV.  Low occupancy xenon binding can produce an anomalous signal similar to these 
other atoms.  In particular, very low occupancy xenon can become confused with chloride 
ions which show a preference for binding to the surface of proteins held in place by 
hydrophobic van der Waals or polar interactions49.   
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Figure 2.9 Theoretical anomalous signal for noble gases and halides 
Xenon and iodine produce sufficient anomalous signal from a small number of partially 
occupied sites.  Lighter group elements such as krypton and bromine have also been used 
successfully as sources of anomalous signal and are comparable in strength to selenium.  
Argon, although similar in strength to chlorine, has not been nearly as successful.  In 
addition to a potentially small number of binding sites, its small size and polarizability 
make binding, based on induced and London interactions, extremely weak. 
 
2.3.1 Xenon Pressurization 
Derivatization by xenon gas has recently gained popularity in solving structures due to 
improvements in techniques which plagued early experiments.  Pressurization chambers  
such as the Hampton Research Xenon Chamber mean no longer having to expose crystals to 
extreme changes in temperature and pressure and allows for much better measurement of 
gas pressure; in the older quartz capillaries, experimenters reported a failure rate of 
70%28,50.  One of two other major problems was that xenon gas within the capillaries 
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absorbed x-rays which meant long exposure times25.  The other problem was the formation 
of xenon hydrate which is formed by water and xenon in closed cavities51.  Both problems 
are solved using the Hampton Research Xenon Chamber in combination with modern 
cryocooling techniques whereby crystals are first pressurized by xenon gas and then 
quickly plunged into liquid nitrogen so as to “freeze in” the xenon. 
Presently, SAD data has been used to solve nearly half of the structures determined by 
experimental phasing techniques52.  Further, it has been estimated that approximately 50% 
of all proteins are able to bind noble gases based on studies performed on nine proteins of 
which five produced sufficient phasing information, two gave no phasing information 
indicating little or no xenon binding, and two were non-isomorphous32.  For proteins which 
are difficult to phase, noble gases such as xenon are a reasonable method to be used to 
solve the phase problem. 
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3.0 Materials & Methods 
 
Table 3.1 Proteins & reagents 
Item Supplier 
100% Glycerol Hampton Research 
Ammonium Sulphate Acros Organics 
Ethylene Glycol Hampton Research 
Glucose Isomerase Hampton Research 
HEPES Sigma-Aldrich 
HEWL Sigma-Aldrich 
Potassium Sodium Tartrate Sigma-Aldrich 
Sodium Acetate Trihydrate EMD Millipore 
Sodium Chloride EMD Millipore 
Thaumatin Sigma-Aldrich 
Thermolysin Hampton Research 
Tris Base Fisher Scientific 
 
3.1 Proteins 
3.1.1 HEWL 
Hen egg white lysozyme is an enzyme which damages bacteria by attacking the 
carbohydrate chains which make up the bacterial cell wall.  Breaking these carbohydrate 
chains causes bacteria to burst under their own internal pressure.  High purity lysozyme 
powder can be purchased from commercial companies making it cheap and easy to grow 
crystals.  Crystals grown from HEWL are particularly stable and durable for protein 
crystals and as such are ideal for teaching, testing, and demonstrations.  For these reasons, 
lysozyme was selected as a protein standard on CMCF beamlines and as a test crystal for 
this study. 
Lyophilized hen egg white lysozyme powder (product number HR7-110) was purchased 
from Hampton Research and used without further purification.  Crystals were grown by the 
hanging drop vapour diffusion method (Figure 3.1) by mixing 6.5 µl reservoir solution 
containing 150 µl of NaCl (20% w/v), 50 µl of 1.0M sodium acetate (pH4.8), 125 µl of 
ethylene glycol and 175 µl water with 3.5 µl of 75 mg/ml protein solution in 0.1M sodium 
acetate (pH 4.8) (Crystallization protocol taken from Hampton Research website).   
26 
 
 
 
 
Figure 3.1 HEWL crystals 
Crystals appeared within a couple of hours and grew to dimensions of approximately 
0.20x0.10x0.10 mm3 after 3 or 4 days. 
 
3.1.2 Thermolysin 
Thermolysin is a metalloproteinase enzyme containing one zinc ion and four calcium ions 
whose function is to catalyze the hydrolysis of peptide bonds of hydrophobic amino acids 
on the amino side.  Thermolysin powder (product number HR7-098) was purchased from 
Hampton Research and used without further purification.  Crystals were grown by the 
hanging drop vapour diffusion method (Figure 3.2) by mixing 4.6 µl of reservoir solution 
containing 187 µl of 2.0M ammonium sulphate, 50 µl of 1.0M tris (pH8.5), 120 µl of glycerol 
(50% v/v), and 143 µl of water with 5.4 µl of 25 mg/ml protein solution in 0.1M NaOH 
(Crystallization protocol taken from Hampton Research website).   
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Figure 3.2 Thermolysin crystals 
Crystals appeared within 24 hours and grew to dimensions of approximately 
0.40x0.10x0.10 mm3 after 3 or 4 days. 
 
3.1.3 Glucose Isomerase 
Glucose isomerase catalyzes the isomerization reaction between glucose and fructose.  The 
reaction is reversible and goes to equilibrium so that there are approximately equal 
concentrations of glucose and fructose.  Glucose isomerase can be crystallized by many 
different methods and by a wide variety of screen conditions which makes it another great 
candidate for study and learning.  Glucose isomerase (product number HR7-102) was 
purchased from Hampton Research pre-crystallized (Figure 3.3) and supplied as a 
suspension in the following medium: 33 mg/ml in 6mM tris hydrochloride (pH adjusted 
to7.0), 0.91M ammonium sulphate, 1mM magnesium sulphate.  Cryoprotection for glucose 
isomerase crystals was a combination of the supplied suspension medium mixed with 
glycerol for a glycerol concentration of 25% v/v. 
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Figure 3.3 Glucose isomerase crystals 
Crystals came pre-crystallized from Hampton Research.  Suitable crystals selected for 
diffraction studies had dimensions of 0.15x0.15x0.15 mm3.   
 
3.1.4 Thaumatin II 
The thaumatins are a family of proteins which are known mainly for their use as low 
calorie sweeteners and flavour modifiers.  They are intensely sweet and although they have 
a different taste from sugar, they may be up to thousands of times sweeter. Thaumatin is 
primarily a combination of the proteins thaumatin I and thaumatin II the latter of which 
was used for this study.  Thaumatin II powder (product number T7638-25mg) was 
purchased from Sigma Aldrich and used without further purification.  Crystals were grown 
by the hanging drop vapour diffusion method (Figure 3.4) by mixing 5 µl of reservoir 
solution containing 50 µl of 0.5M Hepes (pH 7.0), 450 µl of 1.0M sodium potassium tartrate 
with 5 µl of 25 mg/ml protein solution in 0.5M Hepes (pH 7.0)53.  Cryoprotection solution 
for thaumatin was composed of 130 µl of glycerol, 50 µl of 0.5M Hepes, and 320 µl of 1.0M 
sodium potassium tartrate (pH 7.0) for a final glycerol concentration of ~25% v/v. 
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Figure 3.4 Thaumatin II crystals 
Crystals appeared within 3 days and grew to dimensions of approximately 0.30x0.15x0.15 
mm3 after a week.   
 
3.2 Xenon Gas 
Research grade xenon gas was purchased from Praxair (product number RS-ELB50).  This 
gas was used in combination with the Hampton Research Xenon Chamber and Xenon 
Recovery System to produce derivatives of each protein. 
 
3.3 Hampton Research Xenon Chamber & Xenon Recovery System 
The Hampton Research Xenon Chamber™ (product number HR4-791) (Figure 3.5) is a 
pressure chamber designed to produce derivatives of protein crystals using xenon or other 
noble gases.  The chamber is safely able to handle gas pressures up to 600psi above which 
the gas is vented via safety valve.  The Xenon Recovery System™ (product number HR4-
797) (Figure 3.6) was used in conjunction with the xenon chamber.  The recovery system is 
a simple mechanical hand pump which helps to get the most out of xenon gas cylinders.  
The full setup and user manuals for the xenon chamber, xenon recovery system, and 
pressure regulator (product number HR4-793) (Figure 3.7) may be located and 
downloaded at the Hampton Research website. 
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Prior to Derivatization, setup and pre-operation steps were taken to ensure proper 
operation during derivatization.  The xenon pressure regulator (Figure 3.7) was attached to 
the xenon tank using a crescent wrench.  The other end of the pressure regulator where the 
black needle valve is located (32) was attached to the xenon recovery system inlet (26) by 
quick connector.  The gas outlet on the xenon recovery system (22) was attached to the 
inlet on the xenon chamber (Figure 3.5, 39) also using a quick connector.  At this point all 
valves on all equipment as well as the piston in the xenon recovery system were in the 
closed positions.  The xenon chamber itself was left open with the magnetic base (15) 
moved out of the way along the glide tracks (11).   
Next the valve on the xenon gas tank was opened followed by the pressure regulator T-
valve (31) on the pressure regulator.  This was indicated by the gas pressure on the xenon 
gas tank matching the tank gauge on the pressure regulator (29).  The gas lines underwent 
a couple of purging cycles to ensure that there was only xenon in the lines.  This process 
should be done sparingly since xenon gas is relatively costly and should not be wasted.   
Purging the gas lines was performed first by turning the 3 way valve on the xenon chamber 
(5) to “Apply Pressure to Chamber”.  The black needle valve on the pressure regulator (32) 
was opened and the 3 way valve on the recovery system (19) was set to “Fill Gas to Pump”.  
This allowed gas to flow from the xenon tank through the pressure regulator and into the 
xenon recovery system.  Turning the 3 way valve on the recovery (19) system to “Apply Gas 
to Chamber” cut off the gas from the xenon tank and allowed the gas in the recovery system 
to flow through the xenon chamber and out into the atmosphere.  Repeating this process 
one or two more times effectively purged the gas lines. 
Before harvesting crystals for derivatization, steps were taken to ensure that the crystals 
would not dehydrate and become damaged during derivatization.  This was done simply by 
pipetting a small amount of mother liquor from the hanging drop vapour diffusion well into 
a small vial with wick paper (33) and placing it in the xenon chamber.  To begin, a small 
square of wick paper was cut and placed around the interior of the xenon chamber vial.  
200µL of mother liquor was pipetted into the vial and soaked up by the wick paper.  Mother 
liquor was then added in 50µL increments and the vial turned upside down until the 
amount of mother liquor was almost able to form a drop and fall out of the vial.  This 
ensured that there was sufficient mother liquor to provide humidity during derivatization 
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but not so much that the crystal would be sitting in liquid.  The vial with wick paper and 
mother liquor was then placed inside the Xenon Chamber and the system is ready to 
produce derivatives.  
 
    
 (a) Front view (b) Side View 
Figure 3.5 Hampton Research Xenon Chamber 
 
1. Dewar Dock   2. Chamber Platform  3. Chamber Pressure Gauge 
4. Slow Release Gas Valve  5. 3 Way Valve  6. Xenon Chamber 
7. Chamber Lock   8. Lock Lever Stop Screw 9. Lock Lever 
10. Left Guide Stop Screw  11. Guide Tracks  12. Magnetic Base Release 
13. Plunger Handle   14. Plunger   15. Magnetic Base   
16. Right Guide Stop Screw  17. Safety Shield  18. Dewar    
19. Dewar    39. Gas Inlet 
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 (a) Front view 
 
 
 (b) Side view 
Figure 3.6  Hampton Research Xenon Recovery System 
19. 3 Way Valve            20. Pressure Gauge 21. Piston Shell 22. Feed Line  
23. Chamber Connector      24. Connector Base 25. Piston Handle 26. Gas Tank Inlet 
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Figure 3.7 Xenon Gas Pressure Regulator 
27. Quick Connector  28. Regulated Pressure Gauge 29. Xenon Tank Gauge 
30. Xenon Gas Tank Inlet 31. Pressure Regulator Valve – T-Valve 
32. Black Needle Valve 
 
 
3.4 Crystal Harvest & Cryoprotection 
Immediately prior to xenon derivatization, crystals were harvested using an 18mm 
Mounted CryoLoop™ of an appropriate nylon loop size such that the crystal roughly fills the 
entire loop.  The CrystalCap Copper Magnetic™ with attached Mounted CryoLoop™ (34) 
was placed on the end of a magnetic wand (37) for easy manipulation during harvest.  
Crystals were harvested by hand using the magnetic wand under a microscope.  
Cryoprotection, if required, was performed prior to xenon derivatization since any attempt 
to cryoprotect crystals after xenon derivatization results in xenon gas diffusing out of 
crystals before they can be frozen. 
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Figure 3.8 Cryocrystallography tools 
33. Mini-Vial with wick paper  34. Crystal Cap Copper Magnetic™ 
35. Crystal Cap Copper Magnetic™ Vial with Magnetic Base 
36. Crystal Cap Copper Magnetic™ Vial Clamp 
37. Crystal Cap Copper Magnetic™ Wand 
38. Crystal Cap Copper Magnetic™ Transfer Tool 
 
 
3.5 Derivatization 
Following harvest, CrystalCap Copper Magnetics™ with mounted crystals were removed 
from the magnetic wand by hand and placed on the magnetic base of the plunger (15) on 
the Xenon Chamber.  The plunger (15) was slid along the guide tracks (11) to the left guide 
stop screw and lowered into the chamber.  Once the chamber lock was closed (9), the 
sealed chamber was prepared to accept xenon gas.  In order to get the most out of xenon 
gas tanks, the Xenon Chamber (Figure 3.5) was used in combination with the Xenon 
Recover System (Figure 3.6).   
To begin, the piston handle on the Xenon Recovery System (25) was turned so that the 
piston was in the fully extended position.  Then with the xenon gas tank valve, the pressure 
regulator T-valve (31), and the black needle valve (32) all set to open, the 3 point valve on 
the Xenon Recovery System (19) was set to the “Fill Gas to Pump”.  This allowed gas to flow 
freely from the xenon gas tank into the Xenon Recover System.  When the desired gas 
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pressure had been reached as indicated by the pressure gauge on the Xenon Recovery 
System (20), the 3 point valve on the Xenon Chamber (5) was set to “Hold Pressure” and 
the 3 point valve on the Xenon Recovery System (19) was set to “Fill Gas to Pump”.  This 
configuration trapped the xenon gas in the Xenon Recovery System neither allowing gas to 
flow from the xenon gas tank into the Xenon Recovery System nor out of the Xenon 
Recovery System into the Xenon Chamber.  At this point, the gas pressure in the Xenon 
Recovery System did not need to be as high as the desired pressure for derivatization.  The 
pressure could now be increased by turning the piston handle (25) without having to use 
additional xenon gas. 
To begin derivatization, the 3 point valve on the Xenon Recovery System (19) should be set 
to “Fill Gas to Pump” followed by very slowly turning the 3 point valve on the Xenon 
Chamber (5) from “Hold Pressure” to “Apply Pressure”.  The rush of xenon gas into the 
chamber caused by abrupt changes in gas pressure sometimes resulted in crystals being 
blown out of the nylon loop.  A very slow change in pressure over several seconds was 
necessary to ensure that crystals were not lost and xenon gas was not wasted. 
The pressure within the xenon chamber was monitored using the Xenon Chamber pressure 
gauge (3).  To increase this pressure, the piston handle on the Xenon Recovery System (25) 
was turned by hand until the Xenon Chamber pressure gauge (3) reached the desired value 
for derivatization.  The Xenon Chamber pressure was held constant by turning the 3 point 
valve on the Xenon Chamber (5) to “Hold Pressure” for the duration of derivatization.   
Following derivatization, the xenon gas pressure was vented by turning the 3 way valve on 
the Xenon Chamber (5) to “Release Pressure”.  This was also done very slowly over several 
seconds to prevent crystals from being blown out of the nylon loop.  After the gas in the 
chamber had been completely vented, the chamber was opened using the lock lever (9).  
The plunger (14) was then raised and the CrystalCap Copper Magnetic™ (34) with mounted 
crystal was removed by hand, placed on the end of a magnetic wand (37), and quickly 
immersed in a nearby dish of liquid nitrogen to trap the xenon gas within the crystal for 
immediate data collection or for long term storage.  Total time elapsed in between xenon 
gas pressure release and flash cooling in liquid nitrogen was not more than 5-8 seconds. 
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3.6 Crystallographic Software 
3.6.1 MxDC 
Mx Data Collector (MxDC) is the in house developed, graphical user interface software used 
on the CMCF beamlines for data collection.  It allows users control over various aspects of 
beamline operation such as beamline setup, sample management, fluorescence scans, 
screening, data collection, and data processing4,54. 
 
3.6.1.1 Data Processing 
The in house developed, automated data processing pipeline, AUTOPROCESS was used at 
CMCF54.  The main engine of AUTOPROCESS is XDS55 but it also makes use of other well 
established software packages such as XSCALE, XDSSTAT, BEST (strategy), CCP4 
(ctruncate, f2mtz), POINTLESS (space group determination), and LABELIT.DISTL (ice ring 
detection).  This allows for fully automated experiment planning and data processing 
requiring only minimal human intervention.  AUTOPROCESS is also fully integrated with 
MxDC such that datasets collected using MxDC can be processed using AUTOPROCESS 
directly from the MxDC GUI. Processing reports are then available via the web through 
MxLIVE4,54.  AUTOPROCESS is currently only available at the CLS but it has been used 
successfully on some datasets from other labs. 
 
3.6.2 PHENIX 
Python-based Hierarchical ENvironment for Integrated Xtallography (PHENIX) is a highly 
automated, python-based graphical user interface developed by Paul Adams et al. which 
hosts a variety of tools for the analysis, validation, and manipulation of x-ray diffraction 
data56.   Additionally, PHENIX includes fully automated structure solution capability using 
the AutoSol wizard for experimental phasing and the AutoBuild wizard for model building 
and improvement thorough iterative model building, density modification, and refinement. 
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3.6.2.1 HySS 
The Hybrid Substructure Search (HySS) is a highly-automated module in the Phenix 
package which locates heavy atom substructures.  It requires a reflection file for input as 
well as the number of expected sites and outputs the heavy atom coordinates along with a 
correlation score describing how well the solution fits the data.  The search method uses a 
systematic multi-trial approach using direct space Patterson followed by reciprocal space 
Patterson, then dual-space direct methods, and finally automatic comparison of solutions 
with automatic termination detection56,57.   
The method employed above begins with a test substructure.  The Patterson map is 
calculated for the test substructure and is compared to the Patterson map computed from 
the data.  Similarly, this type of calculation is performed in direct space using reflection 
intensities.  Again a test substructure is created and its reflection intensities are calculated 
and compared to the data.  The next step uses starting phases obtained from Patterson 
maps to obtain better than random initial phases for dual space recycling.  To understand 
dual space recycling requires some knowledge of convolutions insofar as a convolution in 
real space is essentially multiplication in Fourier space.  With that in mind, the Patterson 
function is a convolution in direct space that leads to squaring in reciprocal space as in 
equation 2.14.  Now the opposite of that is the tangent formula (equation 2.13) where 
convolution in reciprocal space leads to squaring in direct space.  This self-consistency 
leads to dual-space recycling where manipulation of phases in reciprocal space based on 
the tangent formula is recycled back and forth with direct space analysis56,57.  
For actual substructure construction, a two-atom substructure is chosen at random 
knowing only the positions of the two atoms relative to one another within the unit cell.  
The substructure is then translated randomly throughout the unit cell and is given a 
correlation score for each position.  Using a pair of two-atom substructure coordinates 
which scored well, the previous step is repeated for a third atom by adding a third atom to 
the substructure while keeping the first two atoms fixed.  This process is repeated until the 
desired number of atoms in the substructure has been generated56,57.   
Substructures which score well are selected for dual space recycling.  Dual space recycling 
corrects inaccuracies in the initial substructure and itself is graded as a correlation 
between calculated and observed intensities.  Finally, HySS employs the random omit 
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technique where substructure atoms are randomly omitted by only searching for 90% of 
the desired number of atoms of which 2/3 are randomly selected for recycling56,57. 
 
3.6.2.2 AutoSol 
The AutoSol wizard is a highly automated experimental phasing module which allows 
much flexibility for advanced users.  AutoSol requires only a reflection file to run but other 
files such as sequence files and heavy atom coordinate .pdb files may also be provided for 
improved performance.  AutoSol then runs a series of PHENIX tools beginning with 
phenix.solve to scale data sets, followed by phenix.xtriage for twinning analysis and 
anisotropy correction, and then phenix.hyss which determines the heavy atom 
substructure if not already provided by phenix.hyss.  Ab initio phasing is then carried out 
by phenix.phaser or phenix.solve followed by density modification performed by 
phenix.resolve.   Finally, a round of automated model building is performed by 
AutoBuild56,58. 
 
3.6.2.2.1 Figure of Merit 
The method used by AutoSol for determining the success of initial phases is known as a 
figure of merit (FOM).  The FOM is a numerical score from 0 to 1 and is defined as the 
cosine of the lack of closure error, ε(φ), which results from the discrepancy between 
theoretical and observed values as shown in Figure 3.9.  A FOM of 0.3 is near the minimum 
value for useful phase information and corresponds to ε(φ)=72.5.  Figure of merit values 
greater than 0.3 are good and a figure of merit greater than 0.5, ε(φ)=60, is very good56,59. 
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Figure 3.9 Lack of closure error59 
A vector diagram representation of the lack of closure error, ε(φ).  In theory, the vectors 
representing the structure factors for the protein, FP, and the anomalous substructure, FA, 
should add vectorially to give the structure factors for the protein and anomalous signal 
together, FPA.  Experimentally these vector quantities do not add perfectly and ε(φ) is a 
measure of how well observation agrees with theory.   
 
3.6.2.3 AutoBuild 
The AutoBuild wizard is a model building tool in the PHENIX package which uses 
phenix.resolve for iterative model building and statistical density modification with 
phenix.refine for refinement.  AutoBuild requires the experimental data, an initial electron 
density map, and starting model to run; most of these files are piped directly into AutoBuild 
from AutoSol output files.  Additionally, files such as amino acid sequence files or .pdb files 
of partial models may be provided for improved performance56,60. 
 
3.6.2.4 phenix.refine 
A standard settings run of phenix.refine is called automatically by AutoBuild as part of the 
iterative model building process.  Phenix.refine may also be run separately for additional 
features such as in refinement of f’ and f’’ values for anomalously scattering atoms.  To run 
separately, phenix.refine requires only an experimental data file which includes Rfree 
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values and phases as well as a file containing the starting model coordinates.  Both of these 
files may be piped directly into phenix.refine from AutoBuild output files.  While run 
separately, each round of phenix.refine displays the updated model in accompanied 
molecular graphics software such as Coot61 or PyMol56,62. 
 
3.6.3 Coot 
Coot is a molecular graphics program used in macromolecular model building and 
validation.  The software displays electron density maps and atomic models while 
providing a variety of manual and automated model building tools.  Coot will also interface 
with other programs such as phenix.refine for refinement, validation, and graphics61.  
 
3.6.4 PyMol 
PyMol is molecular visualization software used for production of publication quality 
images of molecular models62. 
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4.0 Results 
4.1 Optimal Conditions for Xenon Derivatization 
Xenon binding is essentially complete on a time scale of minutes and therefore should not 
require xenon pressurization for longer than 5 minutes18,33–35.  Additionally, derivatives 
had previously been produced using a wide range of xenon pressures (1-100 bar or 14.5-
1450 psi)18.  Data were collected for a total of 33 HEWL crystals with xenon gas pressures 
ranging from 50-500 psi with full data tables located in Appendix A.  It was discovered that 
subjecting crystals to high pressure (500 psi) for a long period of time (60 min) neither 
improved nor adversely affected the crystal or data quality.  Further, 150 psi was 
determined to be the minimum pressure required to successfully phase HEWL.  Xenon 
pressures below 150 psi yielded insufficient anomalous signal to solve the phase problem.  
Therefore it was decided that 300 psi was the optimal pressure for xenon phasing without 
subjecting crystals to unnecessarily high gas pressures. 
 
4.2 Data Collection 
Diffraction data were collected at the Canadian Macromolecular Crystallography Facility 
(CMCF) at the Canadian Light Source (CLS) on the 08B1-1 (CMCF-BM) beamline.  Mounted 
crystals were attached to the magnetic goniometer head using a Crystal Cap Copper 
Magnetic™ Transfer Tool (38) and were maintained at 100K for the duration of data 
collection using an Oxford Instruments Cryojet.  Data collection parameters and automated 
data collection was handled using Mx Data Collector (MxDC).  Data collection strategy was 
determined by AUTOPROCESS using six images that were taken in 0.5° pairs at 45° apart 
instead of consecutively; this method gives a better sampling of the crystal lattice.  A 
complete table of data collection parameters and processing results can be located in 
Appendix A. 
 
4.3 Data Processing 
Initial data processing, including generation of reflection (.mtz) files, was performed using 
AUTOPROCESS.  Diffraction data were collected for a total of 45 protein crystals of which 
42 
 
33 were HEWL; HEWL was used mainly as a test protein in order to determine optimal 
data collection and processing parameters.  Initial data processing was performed on all 45 
crystals, including determination of number and location of xenon sites, using HySS.  Using 
XDS55, the strength of the anomalous signal, SigAno, for each resolution shell was 
calculated; this was the first indicator of potential xenon binding.  Multiple runs of HySS 
were performed for each protein looking for anywhere between 2 to 25 xenon sites.  The 
xenon coordinates which had the highest correlation with the data and the fewest number 
of sites were selected for input into AutoSol.   
Input files provided for AutoSol included the experimental reflection data (.mtz) and the 
xenon site coordinates (.pdb) determined using HySS.  A text file containing the one letter 
amino acid sequence for the protein, known as a sequence file (.seq), was included for all 
runs of AutoSol; a sequence file was not necessary for AutoSol to run however since all 
proteins were previously known, a sequence file allowed AutoSol to run automated model 
building more quickly.  In the case of determining protein structures de novo, AutoSol 
would take longer as would manual rounds of model building and refinement.   
Phasing scores based on the xenon sites determined using HySS were determined by 
AutoSol as a figure of merit (FOM); these FOMs are a score of how well the xenon 
coordinates solve the phase problem.  This score is the second indicator of whether or not 
there are anomalous scattering atoms in the protein.  For each type of protein studied, the 
data set which produced the highest FOM was selected for further model building and 
refinement.  A complete data table including FOM for each protein crystal can be located in 
Appendix B.   
 
4.4 Model Building & Refinement 
Automated model building and refinement was performed by AutoBuild.  Input files for 
AutoBuild included the experimental data (.mtz), the initial electron density map (.mtz), 
and the starting model coordinates including heavy atom coordinates (.pdb).  A sequence 
file (.seq) was once again provided.  A standard run of AutoBuild consisting of 3 refinement 
cycles, 6 maximum iterative build cycles, and 15 maximum rebuild cycles was performed 
on one dataset for each protein.  All water molecules added by AutoBuild, as well as any 
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heavy atom coordinates which were determined to have zero occupancy by either AutoSol 
or AutoBuild, were removed from the models and these working models were then 
inspected using Coot.   
Protein models still had missing or incorrect amino acids after automated model building 
particularly those which were terminal residues or residues which coordinate some metals.  
For manual model improvement, coordinates were downloaded from the PDB for each 
protein and these models were superimposed on the working models using Coot’s LSQ 
(least squares fit) feature.  The number of models which was available for comparison for 
each of the proteins depended on previous work performed by other researchers and 
sometimes even included xenon derivatives for direct comparison.  The refined 
experimental electron density and the 2Fo-Fc maps were used to determine the correct 
positions and conformations of amino acids.  In most cases, models from the PDB agreed 
both with one another as well as with the experimental data.  When PDB models did not 
agree with experimental data, the working model was built to fit the experimental data as 
well as possible although PDB models still served as a guide in model building. 
The models were improved to fit the data in Coot as well as possible.  Manual fitting was 
followed by a run of phenix.refine for 8 refinement cycles; additional cycles showed little to 
no improvement and 8 cycles was chosen for all subsequent runs of phenix.refine.  
Alternation between manual fitting in Coot and automated refinement using phenix.refine 
was performed until all non-solvent peaks in the 2Fo-Fc were explained by the working 
model and additional runs of phenix.refine showed over fitting or little to no improvement.  
If models from the PDB showed solvent molecules other than waters, then these molecules 
were only added to the working model when the molecule was present in the 
crystallization conditions and it was obvious that the solvent molecule fit the experimental 
data.  In most cases, it was not obvious that these solvent molecules were present in the 
experimental data and these regions were described instead by waters.  A final run of 
phenix.refine was performed to automatically add waters back into the model.  One last 
inspection of the model in Coot was performed and any waters which did not agree with 
the 2Fo-Fc maps were added or removed as needed.  Estimation of the weakest signal 
which could still be meaningfully described by water molecules was approximated by 
randomly omitting several more obvious waters.  The peaks in the 2Fo-Fc map which 
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described these missing waters ranged from 8 to 15 rmsd and therefore it was assumed 
that anything below 5 rmsd was either very low occupancy water or else map noise.  Model 
building and refinement was complete after all peaks in the 2Fo-Fc map above 5 rmsd were 
explained. 
 
4.4.1 Anomalous Refinement 
A final round of refinement using phenix.refine was performed on each protein in order to 
differentiate between xenon sites and other anomalously scattering atom sites.   
Phenix.refine has the capability to refine the anomalous signal, f’’, coming from anomalous 
scattering atoms and was run as described earlier for 8 refinement cycles but this time 
including refinement of anomalous groups.  Each anomalously scattering atom site was 
defined as its own anomalous group so that each would be refined separately.  An initial 
value of f’’=0.0 was provided to phenix.refine; this value was chosen so that anomalous 
refinement would not be biased.  Furthermore, it was not certain which sites nor how many 
were actually xenon and not some other anomalously scattering atom.   
PHENIX is cutting edge crystrallographic software that is constantly being improved 
upon56.  Over the course of learning to use it, the PHENIX package has become increasingly 
robust with many features and options added.  Enabling alpha test mode in the PHENIX 
software allowed testing of the new features as was the case for the final step of refining 
anomalous groups, in particular.  Refinement of anomalous groups was being worked on 
presently and mail correspondence between myself and PHENIX developers was necessary 
to work out some bugs in this feature.  Full data collection statistics are shown in Table 4.1.   
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Table 4.1 Data collection statistics 
  Lysozyme Thermolysin Glucose Isomerase Thaumatin II 
Data-collection parameters 
        Beamline 08B1-1 (CMCF-BM), 
CLS 
08B1-1 (CMCF-BM), 
CLS 
08B1-1(CMCF-BM), 
CLS 
08B1-1 (CMCF-
BM), CLS 
    Energy (keV) 7 7 7 7 
    Wavelength (Å) 1.7712 1.7712 1.7712 1.7712 
    Temperature (K) 100 100 100 100 
    Oscillation range (°) 0.5 0.5 0.5 0.5 
    No. of images 540 542 551 580 
    Exposure time per frame (s) 4 4 8 3 
Data-integration statistics 
        Space group P43212 P6122 I222 P41212 
    Unit Cell parameters 
            a (Å) 79.13 92.93 92.66 57.87 
        b (Å) 79.13 92.93 98.07 57.87 
        c (Å) 36.92 129.67 101.94 150.23 
        α (°) 90 90 90 90 
        β (°) 90 90 90 90 
        γ (°) 90 120 90 90 
    Resolution limits (Å) 39.57-2.02 
(2.15-2.02) 
46.45-2.03 
(2.15-2.03) 
48.98-2.03 
(2.15-2.03) 
45.83-2.03 
(2.15-2.03) 
    Total no. of reflections 130936 552511 269427 308718 
    No. of unique reflections 12886 40015 53137 30059 
    Multiplicity 10.2 13.8 5.1 10.3 
    Completeness (%) 88.2 (51.5) 98.9 (93.2) 91.6 (56.7) 95.4 (73.9) 
    Rmeas* (%) 3.1 (7.2) 5.1 (20.4) 7.8 (39.6) 2.7 (4.4) 
    Mean I/ς(I) 59.2 (30.4) 39.8 (10.2) 22.5 (4.4) 70.3 (39.2) 
    Molecules per asymmetric unit 1 1 1 1 
    Solvent content (%) 38.0 45.9 53.7 54.5 
Refinement 
        Resolution (Å) 39.57-2.02 46.45-2.03 48.98-2.03 45.83-2.03 
    Rwork/Rfree 0.14/0.22 0.13/0.18 0.13/0.18 0.12/0.17 
    No. of reflections 11580 36500 50520 27116 
    No. of atoms 1178 2900 3549 1937 
    B factor from Wilson plot (Å2) 12.2 16.1 12.5 9.88 
    B factor (Å2) 16.4 21.9 20.5 14.5 
    Estimated coordinate  
    error (Å) 0.2 0.19 0.17 0.17 
    R.m.s.d. bond lengths (Å) 0.006 0.008 0.007 0.007 
    R.m.s.d. angles (°) 1.027 1.124 1.021 1.054 
     
Ramachandran plot 
            Favoured (%) 97.6 96.2 96.9 98.6 
        Allowed (%) 2.4 3.8 3.1 1.4 
    Xenon Bound Yes Yes Yes No 
Bijovet pairs were not merged for data processing. 
Cutoff based on experimental geometry constraints at 7keV. 
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5.0 Discussion 
5.1 Proteins 
HEWL was selected as the main test protein for several reasons.  Learning how to grow 
protein crystals was the initial goal.  Lysozyme crystalizes quickly producing robust 
crystals which are ideal for running tests.  Secondly, a test protein provided the 
opportunity to establish a method and to hone data collection and processing techniques.  
Finally, lysozyme is known to bind xenon.  The PDB contains a large number of deposited 
lysozyme structures due to its being such a common test protein.  This includes a lysozyme-
xenon derivative (1C1030) which shows three binding sites for xenon.  Thermolysin was 
selected from a list of proteins which were known to bind xenon and of which only 
thermolysin could be crystallized.  In addition to these, thaumatin II and pre-crystallized 
glucose isomerase were available for study although neither had previously been shown to 
bind xenon.  In total, data were collected for 45 protein crystals of which 33 were lysozyme, 
9 were thaumatin II, 2 were thermolysin, and 1 was glucose isomerase.  A structure was 
built for each protein using the anomalous signal at 7keV.  
 
5.2 Wavelength selection 
As shown in Figure 2.7, xenon has a very high anomalous signal in the range of most 
crystallography beamlines.  Xenon’s high anomalous signal means strong anomalous data 
can be obtained even very far from any absorption edges.  In xenon’s case, the anomalous 
signal increases with increasing wavelength until the L-I edge located at 2.27Å.  It was 
experimentally established that without the use of a helium box, the optimum energy for 
low energy data collection is 7keV63 based on a compromise between anomalous signal 
from xenon and absorption of scattered x-rays.   
Data collection at 7keV (1.77 Å) provided sufficient anomalous signal to solve the phase 
problem for each of the four proteins and it was not necessary to attempt data collection at 
a lower energy.  Had phasing been unsuccessful, data collection could have been attempted 
at lower energies.  The use of a helium box would reduce the absorption of scattered x-rays 
allowing data collection closer to the L-I edge.  This would be particularly beneficial for 
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extremely low occupancy xenon sites or for very large proteins with a low number of xenon 
binding sites. 
 
5.3 Anomalous signal 
The first indicator of xenon binding was determined using XDS (Figure 5.1) as the mean 
anomalous difference (SigAno) in units of the estimated standard deviation, ς: 
 
        
           
 
 (5.1) 
 
SigAno is the total anomalous signal from all anomalous scatterers in the protein and 
therefore it is still not known whether or not xenon binding has occurred.  A strong 
anomalous signal at this stage is important, however, as a model of the protein may be built 
which allows further analysis of anomalous substructure.  For each of the four proteins 
examined, there was sufficient anomalous signal to move on to substructure determination. 
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Figure 5.1  Anomalous signal vs Resolution 
AUTOPROCESS calculates anomalous signal and breaks it up into resolution bins.  A graph 
summarizing the data shows that anomalous signal peaks in the mid-low resolution range. 
A sharp drop off in anomalous signal occurs around 3-2Å for most of the proteins 
illustrating the importance of obtaining good quality mid-low resolution data.   
 
5.4 Anomalous substructure 
For substructure determination, all anomalous scatterers were treated as xenon.  It was not 
yet known which xenon sites were true partially occupied xenon sites and not simply some 
other anomalous scatterer whose anomalous signal resembles that of a partially occupied 
xenon site (Figure 2.8).  Ideally when looking at a graph of the xenon occupancy vs site 
number, one would hope to see a small number of high occupancy sites followed by a steep 
drop; this may indicate xenon binding18.   Next would come several smaller peaks due to 
other anomalous scatterers and possibly some medium to low occupancy xenon.  Finally, 
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any very low occupancy sites would usually be noise which would be removed in 
subsequent model building and refinement. 
Initial data (Figure 5.2) from test protein HEWL shows 1-3 possible binding sites for xenon 
followed by a number of lower occupancy sites.  Some of these lower occupancy sites may 
be heavier atoms or solvent.  Also, given that HEWL was the only protein in which chlorides 
were present during crystallization, it is likely that many of these low occupancy xenon 
sites are actually chloride.  
Thermolysin and glucose isomerase proved to be much better test proteins as they both 
have one high occupancy site followed by a steep drop which suggests at least one binding 
site for xenon.  The remaining few sites are likely a mix of lower occupancy xenon sites and 
metals.  The curve of thaumatin II suggests little to no xenon binding even though 
thaumatin II had a strong anomalous signal previously.  The strong anomalous signal in 
thaumatin II could be a combination of many low occupancy xenon sites although this is 
unlikely. 
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Figure 5.2  Xenon site occupancy vs Site number 
HySS finds the xenon sites using anomalous maps which have been calculated from 
anomalous data.  It treats all anomalous peaks as xenon and normalizes the scale by giving 
the largest off-origin peak an occupancy of 1 regardless of actual occupancy.  All other 
peaks are then some fraction of the largest off-origin peak.   
 
5.5 Figure of Merit 
The anomalous substructures as determined by HySS yielded good FOMs for each of the 
four proteins (Table 5.7).  The slightly lower FOM coming from the glucose isomerase was 
partially due to the lower multiplicity of the data collected and not necessarily due to the 
absence of anomalous scatterers.  Upon solving the phase problem, initial models of each 
protein were built automatically using AutoSol and approximate starting occupancies for 
each anomalous scatterer were calculated.  It is common during cycles of model building 
and refinement for Phenix software to append or remove anomalous scatterers from the 
anomalous substructure model in order to better fit the data56,59. 
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Test protein HEWL showed a pair of very low occupancy sites followed by a number of 
lower occupancy sites (Figure 5.3).  This indicates two potential xenon sites followed likely 
by a combination of chloride ions and native sulfurs.  In the case of thaumatin II, there are 
no high occupancy peaks and because of that, as with the case of lysozyme, a large number 
of peaks belonging to native sulfurs are included in the anomalous substructure as they are 
providing the majority of the anomalous signal.  Once again, thermolysin and glucose 
isomerase were very good test proteins each showing a single high occupancy peak 
indicative of xenon binding.  The remaining peaks are likely a combination of lower 
occupancy xenon sites, metals, and native sulfurs. 
 
 
Figure 5.3  Xenon site occupancy vs Site number 
AutoSol builds a model of the protein using the anomalous data and the anomalous atom 
sites determined by HySS.   Once again, all anomalous scatterers are treated as xenon and 
each is given an approximate occupancy based on the initial model.  The large number of 
sites in lysozyme and thaumatin II is due to the lack of any strong anomalous scatterers in 
the protein.  This results in most of the anomalous signal being provided by small native 
sulfurs and, in the case of lysozyme, chlorides as well. 
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Refinement to convergence saw many sites removed from the substructure as they either 
belonged to native sulfurs or were determined to have zero occupancy56.  Thermolysin was 
the best case as there is clearly a single, high-occupancy xenon site (Figure 5.4).   The 
remaining thermolysin sites as well as all sites for the other three proteins were not clearly 
distinguishable as xenon and further investigation was needed.  The large number of sites 
remaining for lysozyme is due to chlorides which were present in crystallization.  In the 
case of thaumatin II, all of the low number sites were removed from the substructure 
having mostly been native sulfurs.  The remaining thaumatin II sites, despite several decent 
occupancies, are most likely just noise. 
 
 
Figure 5.4  Xenon site occupancy vs Site number 
Refinement to convergence removed many peaks leaving only those which were likely not 
noise.   
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5.6 Anomalous Refinement 
The refinement of f’’ values shed some light on the identities of the anomalous scatterers 
(Figure 5.5).  The results for test protein HEWL were promising.  For the first time, 
refinement of f’’ values suggest strong likelihood that sites 1 and 2 are probably true, albeit 
very low occupancy, xenon sites when compared to the other remaining sites.  Thaumatin II 
initially had a very strong anomalous signal followed by a good FOM.  However, of an initial 
25 sites, 17 turned out to be native sulfurs.  The remaining 8 sites are low occupancy, low 
refined f’’, and are likely not actual sites.   
Once again, thermolysin site 1 has a very high f’’ providing further evidence that this is 
almost certainly a true xenon site.  The remaining thermolysin sites are most likely a 
combination of metals having relatively small refined f’’ compared to site 1.  Site 5 shows a 
high occupancy (Figure 5.4) with a low f’’ which indicates that this is not a xenon site.  Site 
6 on the other hand is interesting because of its low occupancy (Figure 5.4) compared with 
its relatively high refined f’’ value (Figure 5.5).  This may indicate a second binding site 
since the software seems to have some difficulty when refining f’’ values for low occupancy 
sites.  In the case of glucose isomerase, neither the occupancies nor the refined f’’ values 
helped to distinguish any of the remaining sites as xenon (Figures 5.4 & 5.5).  There 
remains the possibility that none or all of the remaining glucose isomerase sites are xenons 
and thus further investigation is required. 
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Figure 5.5  Refined f’’ vs Site number 
F’’ refinement in the PHENIX package was still in alpha testing stages at the time of data 
processing.  Although not perfectly accurate, these refined values were still useful when 
trying to distinguish xenon from other anomalous scatterers. 
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5.7 Binding site inspection 
 
Table 5.1 Coordination geometry of common metals64,65 
Element Coordination Ligand 
  Geometry   
Zn 4, 5, 6 S, N, O 
Mg 6 O 
Ca 7, 8, 9 O preferred 
Cu 2, 4, 6 - 
Mn 4, 6 - 
Fe 6 - 
Cl van der Waals49 
Xe van der Waals 
Different metals prefer different numbers and types of ligands.  Xenon gas and chloride 
ions behave differently and prefer to bind based on weak van der Waals forces. 
 
Table 5.1 shows the preferred coordination of common metals including xenon and 
chloride.  Table 5.2 shows known protein-metal bond distances and to which atoms they 
bind.  Xenon does not bond in this manner and instead interacts via van der Waals 
interactions based on the van der Waals radii where distances between xenon and protein 
carbon, oxygen, and nitrogen are the combined xenon-ligand radii of 3.86Å, 3.68Å, and 
3.71Å, respectively.  Based on the aforementioned criteria, binding sites which were likely 
metals were not included in further model building analysis.  Except for a few obvious 
xenon binding sites, the remaining sites must be inspected visually in the refined models.  
Overall, observed protein-metal bond lengths were approximately 10-15% longer than 
expected bond lengths based on statistics taken from the PDB and CSD (Table 5.2).   
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Table 5.2 CSD and PDB bond length statistics for protein-metal complexes66 
  O, O, O, N, S, 
 
 
water Asp or Glu main-chain histidine cysteine 
 
  
monodentate carbonyl 
   Na 2.41** 2.41** 2.38* - - 
 Mg 2.07*** 2.07** 2.26 - - 
 K 2.81* 2.82* 2.74* - - 
 Ca 2.39** 2.36** 2.36** - - 
 Mn 2.19*** 2.15*** 2.19 2.21** 2.35 
 Fe 2.09** 2.04** 2.04 2.16* 2.30** 
 Co 2.09** 2.05*** 2.08 2.14** 2.25* 
 Cu 2.13 1.99* 2.04 2.02** 2.15 
 Zn 2.09*** 1.99*** 2.07 2.03*** 2.31** 
 ***  most reliable, std dev ~0.05Å 
   ** std dev 0.10Å 
    * std dev 0.15-0.20Å 
    
 
no marking is least reliable 
           Small revisions to predicted distances around metal sites in proteins 
  
 
Test protein HEWL sites Xe1 and Xe2 are likely bound xenon from data summarized in 
Figures 5.3-5.5.  The anomalous maps in Figures 5.6 and 5.8 show the presence of 
anomalous scatterers albeit very weak ones.  The weak anomalous signal is the result of 
these both being very low occupancy xenon sites set apart from the other sites only by their 
relatively high refined F’’ values(Figure 5.5).  Xe1 (Figure 5.7) has an occupancy of 0.22 and 
is hydrophobic in nature.  All of the nearest contacts are to carbon atoms and there are no 
contacts within 3.4Å.  This distance is too far to be a metal-protein bond and there is no 
coordination geometry present.   
HEWL site Xe2 (Figure 5.9) is very different from Xe1.  The site is made up of two adjacent 
protein molecules which produce a pocket for xenon along a solvent channel.  Two 
arginines and two threonines from neighbouring protein molecules produce a pair of beta 
sheets between which xenon can bind (Figure 5.10).  This pocket, composed mostly of 
oxygens and nitrogens, shows no coordination geometry typical of metal binding and is 
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larger than Xe1 having no contacts within 3.9Å.  The low 0.14 occupancy of this site may be 
the result of the site being slightly too large for xenon atoms. 
 
Figure 5.6  HEWL Xe1 Fo-Fc and anomalous maps 
A model of likely xenon binding site Xe1 (cyan) and coordinating residues.  The Fo-Fc and 
anomalous maps generated using PHENIX56 are shown to sigma level 3.0 as grey and green 
mesh, respectively.  The low 0.22 occupancy significantly diminishes the anomalous signal 
coming from xenon.  Also shown is the anomalous signal from neighbouring methionine 
sulfur (PyMol62).  
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Figure 5.7  HEWL site Xe1 with distances to coordinating residues 
A model of likely xenon site Xe1 is shown in cyan with distances to neighbouring amino 
acids.  The site is enclosed in a cavity between 3 alpha helices and is composed of mostly 
hydrophobic amino acids.  All of the nearest conacts within 5Å are to carbon atoms; these 
kinds of hydrophobic sites are well known to bind xenon18.  Distances measured to closest 
contacts indicate bond lengths that are too long for metal binding and there is no metal 
bond geometry present (PyMol62).   
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Figure 5.8  HEWL Xe2 Fo-Fc and anomalous maps 
A model of likely xenon binding site Xe2 (cyan) and coordinating residues.  The Fo-Fc and 
anomalous maps generated using PHENIX56 are shown to sigma level 3.0 as grey and green 
mesh, respectively. Once again, a low 0.14 occupancy significantly diminishes the 
anomalous signal coming from xenon (PyMol62).   
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Figure 5.9  HEWL site Xe2 with distances to coordinating residues 
A model of likely xenon site Xe2 (cyan) with an occupancy of 0.14 is shown with distances 
to neighbouring amino acids.  This site has a much different character than that of Xe1.  Xe2 
is located on the edge of the protein trapped between beta sheets of neighbouring protein 
molecules (Figure 5.10).  This site is not a hydrophobic pocket and most of the nearest 
contacts are to nitrogen and oxygen atoms.  The closest contact this time is 3.9Å which is 
too long for a metal bond and there is no metal bond geometry present (PyMol62).   
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Figure 5.10  HEWL intermolecular xenon Site Xe2 
Xenon site Xe2 was the second highest peak in the anomalous maps with an occupancy of 
0.14.  Unlike Xe1 which is bound between three helices within the protein structure, Xe2 is 
bound between two beta sheets of adjacent, symmetry-related protein molecules 
(PyMol62).   
 
Thermolysin xenon site Xe1 (cyan) shows a very strong anomalous signal in the anomalous 
map emanating from the almost full 0.91 occupancy xenon site (Figure 5.11).  Like HEWL 
site Xe1, this site lays buried within the protein, away from the solvent, and in between two 
alpha helices.  The amino acids which make up this site are mostly hydrophobic and include 
a couple of polar uncharged amino acids as well (Figure 5.12).  Once again, there are no 
contacts within 3.7Å as well as a clear lack of coordination geometry.  These aspects further 
support that xenon binding has taken place.   
Thermolysin site Xe6 was selected for further examination due to having both a low refined 
occupancy of 0.16 (Figure 5.4) as well a relatively high refined f’’ value of 3.11 (Figure 5.5).  
Three other sites Xe2, Xe3, and Xe4 all show coordination geometry indicative of calcium 
and have refined f’’ values in between 3.8-4.5 (Figure 4.2).  Xe5 also shows coordination 
geometry this time indicative of zinc.  The weak anomalous signal shown by Xe6 in the 
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anomalous map (Figure 5.13) is due to the low occupancy and accounts for such a low 
refined f’’ value when compared with xenon site Xe1 which had a refined f’’ of 8.24. 
The Xe6 site is close by the main site Xe1 only 7.7Å away and closer to the edge of the 
protein surface.  The site is once again mostly hydrophobic and polar with only a single 
arginine with its side chain facing away from the site.  This site does not show coordination 
geometry and does not appear to be a metal however it differs from other sites observed so 
far due to the short distance to two neighbouring alanine carboxyl oxygens (Figure 5.14).  
These oxygens are located 3.0Å and 3.1Å away and although very short, are once again too 
long for covalent binding42.  Although a bit small, this sort of smaller pocket may serve as a 
temporary pathway or binding site for xenon when pressurized.  Xenon site Xe6 has a 
lower affinity for xenon and becomes populated after the main site Xe1 is full.  Occurrences 
of additional xenon sites appearing as a result of increased xenon pressure have been 
previously observed18. 
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Figure 5.11  Thermolysin Xe1 Fo-Fc and anomalous maps 
A model of likely xenon binding site Xe1 (cyan) and coordinating residues.  The Fo-Fc and 
anomalous maps generated using PHENIX56 are shown to sigma level 3.0 as grey and green 
mesh, respectively. The almost full 0.91 occupancy site produces a strong anomalous signal 
and is strongly identified in the anomalous map (PyMol62).   
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Figure 5.12   Thermolysin site Xe1 with distances to coordinating residues 
A model of xenon site Xe1 (cyan) with an occupancy of 0.91 is shown with distances to 
neighbouring amino acids.  The site is enclosed in a cavity between 2 alpha helices and is 
composed of mostly hydrophobic and neutral amino acids.  Most of the nearest contacts 
within 5Å are to carbon atoms; the shortest contact distance is 3.7Å .  The absence of 
typical metal bond geometry and bond lengths to closest contacts indicate that this is not a 
metal binding site (PyMol62).   
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Figure 5.13  Thermolysin Xe6 Fo-Fc and anomalous maps 
A model of possible xenon binding site Xe6 (cyan) and coordinating residues.  The Fo-Fc 
and anomalous maps generated using PHENIX56 are shown to sigma level 3.0 as grey and 
green mesh, respectively. The low 0.16 occupancy produces a very weak anomalous signal 
similar to those seen in HEWL (PyMol62).   
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Figure 5.14   Thermolysin site Xe6 with distances to coordinating residues 
A model of xenon site Xe6 (cyan) with an occupancy of 0.16 is shown with distances to 
neighbouring amino acids.  Xe6 is located near Xe1 in a coiled region of the protein with 3.0 
Å as  the shortest contact distance.  The absence of typical metal bond geometry and bond 
lengths to closest contacts indicate that this is not a metal binding site.  The absence of 
chlorides in crystallization and the low number of total peaks in the anomalous maps are 
strong indicators that this is probably a low occupancy xenon site (PyMol62).   
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The three sites in glucose isomerase all showed very high refined f’’ and good potential for 
being bound xenon (Figure 5.5).  Of the three sites, the main site Xe1 with occupancy 0.57 
is the only one of the remaining three sites which does not show coordination geometry 
typical of metal binding.  This partially occupied site is strongly identified in the anomalous 
maps and is located in between two asymmetric units (Figure 5.15).  Figures 5.17 & 5.18 
show how four glucose isomerase molecules come together during crystallization to 
produce a binding site for xenon along the solvent channels.  Once again the binding site is 
composed of mainly hydrophobic and polar amino acids as well as two positively charged 
arginines whose residues are facing away from the site.  There are no close contacts within 
3.3Å which further supports that this is not metal binding. 
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Figure 5.15  Glucose isomerase Xe1 Fo-Fc and anomalous maps 
A model of xenon binding site Xe1 (cyan) and coordinating residues.  The Fo-Fc and 
anomalous maps generated using PHENIX56 are shown to sigma level 3.0 as grey and green 
mesh, respectively.  A mid occupancy of 0.57 produces a strong anomalous signal and is 
strongly identified in the anomalous map.  The portion of the model shown in grey is part 
of a nearby symmetry related protein which completes the binding site (PyMol62).   
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Figure 5.16  Glucose isomerase site Xe1 with distances to coordinating residues 
A model of xenon site Xe1 (cyan) with an occupancy of 0.57 is shown with distances to 
neighbouring amino acids.  This site is not a typical hydrophobic pocket and is instead the 
result of crystal packing which produces a cavity in between the ends of  alpha helices of 
neighbouring protein molecules (Figure 4.14, Figure 4.15).  Unexpectedly, there are no 
really hydrophobic amino acids in this binding site and almost all of the nearest contacts 
are to oxygens.  Visual inspection of this site shows that most of these nearby oxygens 
belong to the main chain with many side chains facing away from the bound xenon.  The 
absence of typical metal bond geometry and with distances to oxygens all greater than 3.3Å 
indiate that this is not a metal binding site (PyMol62).   
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Figure 5.17  Glucose isomerase packing symmetry (front view) 
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Figure 5.18  Glucose isomerase packing symmetry (top view) 
A cartoon ribbon representation of glucose isomerase is shown packed with 3 identical 
copies shown in grey to form spherical, repeating structures; xenon is once again shown in 
cyan with magnesium and calcium both in dark green.  The front view (Figure 5.17) shows 
how the xenon (cyan) is bound in between the end of a long alpha helix from one protein 
and a very short alpha helix of an adjacent protein.  Taking a look from the top (Figure 5.1) 
shows how the ASU packs to form large solvent channels enclosed by the proteins.  Within 
these solvent channels exist small, easily accessible pockets for xenon to travel and bind to 
(PyMol62).   
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Based on preliminary data (Figures 5.3-5.5), the occupancies and refined f’’ values for the 
thaumatin II xenon sites indicated that further analysis would not be necessary.  None of 
the sites were obviously xenon meaning that xenon binding likely did not occur in this case.  
The large number of sites located earlier on (Figure 5.3) reflects the fact that there were no 
xenon sites, metals, or any other strong anomalous scatterers.  The strong anomalous 
signal shown in intial processing (Figure 5.2) is a result of 17 native sulfurs in a 207 amino 
acid protein.  The anomalous signal from these sulfurs only barely stands out above noise 
in the maps and is the reason for the high number of initial sites (Figure 5.2).  Since 
chloride was not used in crystallization, these remaining non-sulfur sites are most likely 
simply noise in the anomalous map. 
 
5.8 PDB comparison 
The number and variety of PDB models available for each protein varied and sometimes 
included a xenon derivative.  Each xenon site was compared with sites from as many other 
derivatives as were available.  These comparisons are summarized in Tables 5.3-5.5.  
Comparison for thaumatin II (PDB code: 3AOK67) was not included as there was no 
evidence to suggest xenon binding.  Furthermore, comparison showed no presence of any 
anomalous scatterers in thaumatin II aside from the 17 sulfurs.   
Comparison with other structures yielded some interesting results for test protein HEWL 
(Table 5.3).  Most importantly, xenon sites could be confirmed for both Xe1 and Xe2.  
Interestingly, the higher occupancy site Xe1 and the secondary site Xe2 were reversed with 
the 1C1030 xenon derivative showing a higher occupancy in the Xe2 position than in the 
Xe1 position.  Additionally, the 1C1030 structure showed a third intermediate xenon site 
which was never observed in any of the HEWL crystals examined.  Study of other available 
structures8,30,68 also showed that the large number of initial peaks observed was largely 
due to chloride ions which bind readily along solvent channels.  A large number of chloride 
ions were observed in each of the structures in which chloride was used as an ingredient in 
crystallization.  It is also interesting to note that the hydrophobic main site Xe1 can also 
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bind noble gas krypton while the secondary site Xe2 has displaced solvent which would 
otherwise have been there. 
Comparison of thermolysin structures (Table 5.4) supported xenon binding for site Xe1.  
Metal binding sites Xe2-Xe4 were reported as calcium ions with Xe5 reported as a zinc 
ion69,70.  Interestingly, in the other two thermolysin structures examined, both reported 
four calcium ions while only three calcium ions were ever observed with nothing appearing 
in the anomalous map.  Xe6 is interesting and unusual as discussed previously.  
Comparison with the two other structures, including a xenon derivative, shows that this 
site is usually occupied by solvent.  The lack of chloride during crystallization strongly 
suggests that this is a low occupancy xenon site; observation of this low occupancy xenon 
site has not yet been reported.  Final inspection of the anomalous maps shows that site Xe8 
is not real which is expected given the low occupancy and refined f’’.  It is uncertain as to 
why this peak was not removed automatically during previous model building and 
refinement.  It may have to do with this site’s location in a particularly disordered region 
near a zinc ion in the active site. 
Comparison of glucose isomerase structures71 (Table 5.5) was useful in identifying the two 
metals Xe2 and Xe3 as calcium and magnesium, respectively.  The main site Xe1 has 
replaced water in the native structure and has replaced a chloride ion in the available 
krypton structure.  Observation of xenon site Xe1 has not yet been reported.  It is 
interesting to note that the two krypton sites are unique from the xenon site unlike in the 
case of HEWL where xenon and krypton had one site in common.  It is also noteworthy 
that, in the absence of xenon, chloride has been observed in one case to fill the cavity along 
the solvent channel.  Chloride ions are known to prefer some of the same sites as xenon49 
which suggests that xenon may have to compete with chloride ions, when present, resulting 
in sites which may be partially occupied by both.  In the case of HEWL Xe2, the low xenon 
occupancy and the below theoretical refined f’’ value could be the result of software 
struggling to make sense of a site which is partially occupied by two very different 
elements. 
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Table 5.3 HEWL PDB comparison 
Data * 1C1030 * 1LZ88 * 1QTK30 * 1VAT68 *Cl 
(Xe) (Xe) (Cl ,S) (Kr) (I)   
Xe 1 (0.22) Xe 152 (0.15) - Kr 150 (0.49) -   
Xe 2 (0.14) Xe 150 (0.32) H2O H2O H2O   
Xe 3 (0.33) - - - -   
Xe 6 (0.22) - H2O - H2O   
Xe 7 (0.35) Cl 160 Cl 201 Cl 160 I 301 (0.22)   
Xe 13 (0.30) Cl 165 Cl 205 H2O H2O   
Xe 15 (0.17) Cl 163 Cl 204 Cl 163 H2O   
Xe 16 (0.22) Cl 161 Cl 202 Cl 161 H2O   
Xe 17 (0.35) Cl 162 Cl 203 Cl 162 H2O   
Xe 19 (0.28) - Cl 206 - H2O   
Xe 21 (0.27) H2O Cl 207 H2O H2O   
Xe 22 (0.24) - - - -   
Xe 23 (0.21) H2O H2O H2O H2O   
H2O Xe 151 (0.28) H2O H2O H2O   
- Cl 164 H2O H2O H2O   
H2O - H2O - I 300 (0.36)   
Several PDB structures are compared with the data.  Along with their PDB codes, in 
parentheses is the type of derivative for each structure.  An asterisk next to the PDB code 
indicates that chloride was used as an ingredient in crystallization.  Beside each element is 
the chain number for the element along with occupancy in parentheses when applicable. 
 
Table 5.4 Thermolysin PDB comparison 
My Data 3LS769 2TLX70 
(Xe) (Xe) (native) 
Xe 1 (0.91) Xe 501 (0.81) - 
Xe 2 (0.35) Ca 604 Ca 323 
Xe 3 (0.41) Ca 601 Ca 325 
Xe 4 (0.43) Ca 602 Ca 326 
Xe 5 (0.66) Zn 701 Zn 322 
Xe 6 (0.16) H2O H2O 
H2O Ca 603 Ca 624 
Two PDB structures are compared with the data.  Along with their PDB codes, in 
parentheses is the type of derivative for each structure.  Beside each element is the chain 
number for the element along with occupancy in parentheses when applicable. 
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Table 5.5 Glucose isomerase PDB comparison 
My Data ** 1O1H71 * ** 1MNZ71 * ** *Cl 
(Xe) (Kr) (Native) ** Mg 
Xe 1 (0.57) Cl 1010 H2O   
Xe 2 (0.48) Ca 1001 Ca 390   
Xe 3 (0.47) Mg 1003 Mg 389   
- Kr 1006 (0.20) -   
- Kr 1008 (0.40) -   
Two PDB structures are compared with the data.  Along with their PDB codes, in 
parentheses is the type of derivative for each structure.  An asterisk next to the PDB code 
indicates that chloride was used as an ingredient in crystallization while a double asterisk 
indicates the use of magnesium.  Beside each element is the chain number for the element 
along with occupancy in parentheses when applicable. 
 
5.9 Protein Summary 
Xenon was observed to bind to three out of four proteins as summarized in Table 5.6.  In all 
cases, there was sufficient anomalous signal to locate the anomalous scatterers even for 
thaumatin II which did not bind xenon.  Anomalous signal came not only from xenon but 
from a number of other anomalous scatterers and caused difficulty in accurately assessing 
the phasing power of xenon alone.  Thaumatin II and HEWL were not ideal cases.  The 
absence of any major anomalous scatterers and a high number of sulfurs, and chlorides in 
the case of HEWL, produced maps with upwards of 20 small peaks.  The large number of 
peaks which originate from these light anomalous scatterers made it difficult to identify 
low occupancy xenon binding sites.  Due to the large number of anomalous scatterers in 
these cases, it is difficult to know how significantly xenon contributed to the anomalous 
signal. 
Thermolysin was the cleanest example.  With only two sulfurs and a few metals, the high 
occupancy xenon site played a much more important role in the phasing of this protein.  
The location of the second xenon binding site would also not have been possible as it would 
be obscured by a large number of small peaks.  Glucose isomerase was another very good 
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example with only a couple of metals and 9 sulfurs.  The approximately half-filled xenon 
site and two metals provided the majority of the anomalous signal for the largest of the 
four proteins.  In each case where xenon binding was observed, xenon was not the sole 
contributor to anomalous signal.   
Based on the studies of thermolysin and glucose isomerase, it is probable that a single half 
occupied xenon site is sufficient to phase proteins of this size although a case of xenon 
being the sole contributor of anomalous signal was not observed in this study.  Ribbon 
cartoon representations of each proteins studied along with anomalous scatterers are 
depicted in Figures 5.19-5.22. 
 
Table 5.6 Summary of results 
   
Glucose 
 
 
Lysozyme Thermolysin Isomerase Thaumatin II 
Weight (kDa) 14.3 34.3 43.2 22.3 
Time (min) 5 5 5 5 
Pressure (psi) 300 300 500 300 
Multiplicity 10.1 13.2 5 10.3 
FOM 0.44 0.475 0.371 0.429 
# xenon sites 2 2 1 0 
Occupancy 0.22 0.91 0.57  
 0.13 0.16   
# other anomalous  20 6 11 17 
scatterers     
A summary of xenon binding.  Non-xenon anomalous scatterers are a combination of 
metals, chlorides, and sulfurs.  The lower FOM value for glucose isomerase is likely due to 
the lower multiplicity more than anything else. 
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Figure 5.19  Ribbon cartoon representation of HEWL with bound xenon 
Bound xenon is shown in cyan along with a single sodium ion shown in purple and chloride 
ions shown in light green.  Diffraction data were collected on the 08B1-1 (CMCF-BM) 
beamline from a single HEWL crystal.  Anomalous signal from two low-occupancy xenon 
sites, 10 native sulfurs, and 11 chloride ions at 7keV provided sufficient anomalous signal 
to solve the phase problem (PyMol62). 
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Figure 5.20  Ribbon cartoon representation of thermolysin with bound xenon 
Bound xenon is shown in cyan along with three calcium ions shown in dark green and zinc 
shown in purple.  Also shown in the active site is a stick representation of the amino acids 
valine and lysine.  Diffraction data were collected on the 08B1-1 (CMCF-BM) beamline from 
a single thermolysin crystal.  Anomalous signal from one high-occupancy and one low-
occupancy xenon site, 2 native sulfurs, 3 calcium ions, and a zinc at 7keV provided 
sufficient anomalous signal to solve the phase problem (PyMol62).  
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Figure 5.21   Ribbon cartoon representation of glucose isomerase with bound xenon 
Bound xenon is shown in cyan with one calcium ion and one magnesium ion both shown in 
dark green.  Also shown is a stick representation of tris which was used in the 
crystallization conditions.  Diffraction data were collected on the 08B1-1 (CMCF-BM) 
beamline from a single glucose isomerase crystal.  Anomalous signal from a single xenon 
site, 9 native sulfurs, one calcium ion, and one magnesium ion at 7keV provided sufficient 
anomalous signal to solve the phase problem (PyMol62). 
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Figure 5.22  Ribbon cartoon representation of thaumatin II structure 
Xenon was not found to bind to thaumatin II.  Thaumatin II contains no native or bound 
metals.  Diffraction data were collected on the 08B1-1 (CMCF-BM) beamline from a single 
thaumatin II crystal.  The anomalous signal from 17 native sulfurs at 7keV provided 
sufficient anomalous signal to solve the phase problem (PyMol62). 
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6.0 Conclusions 
Xenon derivative crystals were produced using xenon gas pressures in between 300-500 
psi for 5 minutes.  Producing derivative crystals in this manner, along with data collection 
and processing strategies outlined in this document, will serve as a guide for students and 
researchers who wish to attempt xenon derivatization on their own crystals.  The study of 
HEWL was one of the more difficult proteins investigated and resulted in a strategy which 
can easily be implemented on other proteins.  Results varied but included low-occupancy 
xenon binding and, in one case, no xenon binding.   
Xenon derivatization is a physical method that can be used to produce derivatives when 
production of a SeMet derivative is not possible.  A single partially occupied xenon site, as 
long as it was not too low, should be sufficient to phase proteins of the size investigated in 
this study.  As will often be the case, xenon may provide the majority of the anomalous 
signal but it will be simply a contribution to a signal which may have been sufficient absent 
the xenon.   
 
6.1 Pros & Cons 
The use of xenon for producing derivatives is convenient due to the ease with which 
derivatives may be produced.  In addition to requiring a short 5 minutes to prepare, the 
nature of the mechanical binding means that there is minimal effect on both the protein 
and crystal structures.  The non-covalent, weak-energy van der Waals interactions which 
exist between xenon and proteins makes the process of xenon binding completely 
reversible; this may be demonstrated by releasing xenon gas pressure and allowing xenon 
to diffuse out of the crystal leaving the crystal unchanged.  The minimal change caused by 
xenon binding leads to a high degree of isomorphism with native crystals.  Even though 
isomorphous differences are not used in SAD experiments, a structure which is as close to 
the native structure as possible should be obtained whenever possible. 
The phasing power and nature of xenon is advantageous when compared to other heavy 
atoms used in SAD.  Xenon is much heavier than other SAD anomalous scatterers (Figure 
2.8).  Its large size produces a very strong anomalous signal and does so without chemical 
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alteration characteristic of salt soaks and SeMet.  In addition to global and local changes 
which occur due to radiation damage, heavy atoms are damaged by radiation.  Larger 
atoms are able to absorb a greater amount of radiation23 making xenon superior to other 
SAD scatterers including selenium.  
Furthermore, it has been previously demonstrated18,32 that changing the xenon gas 
pressure may result in additional xenon sites thus producing derivatives which are 
complementary to other types of derivatives.  Xenon is again complementary to other 
derivatives since xenon has affinity for apolar and/or hydrophobic environments and likely 
binds to sites that are different from those of standard heavy atoms.   
As with many other derivatives, it is not certain whether or not xenon binding has taken 
place until after data has been collected and undergone preliminary processing.  After a 
lengthy and high redundancy data collection, xenon binding may not have occurred or 
perhaps the quality of the data was inadequate to measure the anomalous signal.  This 
leads to lost time as there are no guarantees of xenon binding, occupancy of binding, 
number of sites, effects of radiation damage, crystal quality, and diffraction data quality.  
 
6.2 Future Work 
This document will serve as a guide for all those who would attempt xenon derivatization 
on their crystals.  At the time of this writing, an attempt has already been made to perform 
xenon SAD on a protein crystal for Dr. Marie Fraser of the Department of Biological 
Sciences at the University of Calgary.  Unfortunately, the attempt was not successful in 
generating starting phases as the protein either had not bound xenon or the data quality 
was too poor.  
Possible further work includes the use of a helium box whereby absorption of scattered x-
rays by air is reduced by replacing air with helium72,73.  This could be used as a last resort 
in cases where xenon is thought to have bound but where the anomalous signal is very 
weak due to low occupancy xenon sites.  The use of a helium box may also be beneficial in 
cases of very large proteins having an insufficient number and occupancy of xenon sites for 
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phasing to be successful.  In particular, a helium box could be used in conjunction with a 
lower x-ray energy thus maximizing the anomalous signal from xenon by approaching an 
absorption edge without sacrificing anomalous signal lost to air absorption72,73.   
Two xenon sites in this study were observed to be the result of the packing of asymmetric 
units in the crystal structure.  Previous studies have shown that controlled crystal 
hydration may lead to rearrangement of the domains in a crystal74.  In one case, the cycling 
of hydration and dehydration caused one protein, upon dehydration, to pack more 
efficiently into a higher symmetry space group75.  A case like this would be ideal for 
studying the generation of xenon binding sites by controlled crystal hydration. 
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8.0 Appendices 
 
 
Date # Energy Time Pressure Processing Mosaicity Space Multiplicity Resolution (low) Anomalous
Collected (keV) (min) (psi) Score Group a b c (Å) Cutoff (Å)
Jul 28 2011 7 10 400 0.74 0.09 P41212 78.9 78.9 36.8 7 2.03 (9.08) 2.74
Sep 7 2011 7 15 280 0.69 0.19 P41212 78.8 78.8 36.9 4.3 2.03 (9.08) 2.34
Jul 28 2011 7 10 200 0.74 0.18 P41212 78.9 78.9 36.8 4.2 2.03 (9.08) 2.43
Sep 7 2011 7 15 200 0.59 0.16 P41212 78.8 78.8 37 4.5 2.03 (9.06) 3.2
Sep 7 2011 7 15 160 0.64 0.14 P41212 79 79 37 4.3 2.03 (9.08) 3.21
Sep 7 2011 7 15 100 0.72 0.1 P41212 78.8 78.8 36.9 4.3 2.03 (9.08) 3.03
Date # Energy Time Pressure Anom Signal Anom Signal Ano Corr Notes
Collected (keV) (min) (psi) I/σ(I) Rmrgd Completeness (%) Ano Corr Max Total Total
Jul 28 2011 7 10 400 49.18 1.8 100 65 3.082 1.649 60
Sep 7 2011 7 15 280 35.97 2.5 100 50 2.375 1.54 56
Jul 28 2011 7 10 200 49.62 1.8 100 59 3.13 1.749 60
Sep 7 2011 7 15 200 52.09 1.5 100 43 2.454 1.293 38
Sep 7 2011 7 15 160 35.83 2.1 100 49 1.935 1.244 44
Sep 7 2011 7 15 100 41.33 1.9 100 45 2.111 1.352 49
Cell Dimensions
in highest resolution anomalous shell
Appendix A: AutoProcess results from earlier HEWL
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Date # Energy Time Pressure Processing Mosaicity Space Multiplicity Resolution (low) Anomalous
Collected (keV) (min) (psi) Score Group a b c (Å) Cutoff (Å)
Nov 29 2011 1 7 Control Control 0.59 0.25 78.1 78.1 37 5.3
Nov 29 2011 2 7 Control Control 0.65 0.27 78.3 78.3 37 5.2
Nov 30 2011 3 7 Control Control 0.58 0.4 78.2 78.2 37 6.3
Nov 30 2011 4 7 Control Control 0.69 0.17 78.6 78.6 36.9 7.8
Mar14 2012 1 7 60 500 0.76 0.11 79 79 36.9 9.3 2.13 (9.04) 2.19
Mar14 2012 2 7 60 500 0.74 0.14 78.8 78.8 36.9 9.3 2.13 (9.03) 2.33
Mar14 2012 3 7 60 500 0.67 0.14 78.9 78.9 36.8 10.1 2.26 (9.03) 2.33
Mar14 2012 4 7 60 500 0.66 0.14 78.8 78.8 36.8 9.6 2.19 (9.03) 2.26
1 7 5 350 No Crystal
Nov 30 2011 2 7 5 350 0.64 0.23 78.8 78.8 37 8 2.14 (9.08) 2.34
Nov 30 2011 3 7 5 350 0.58 0.41 78.8 78.8 37 7.6 2.2 (9.08) 3.43
Nov 30 2011 4 7 5 350 0.54 0.51 78.9 78.9 37 7.6 2.35 (9.08)
Dec14 2011 1 7 5 300 0.7 0.16 78.9 78.9 36.9 9.2 2.2 (9.08) 2.34
Dec14 2011 2 7 5 300 0.67 0.13 P41212 78.8 78.8 36.9 10 2.27 (9.08) 2.34
Dec14 2011 3 7 5 300 0.58 0.21 78.8 78.8 36.9 6.9 2.34 (9.08) 2.34
Dec14 2011 4 7 5 300 0.61 0.2 P41212 79.1 79.1 36.9 10.1 2.03 (9.08) 2.03
Dec14 2011 1 7 5 250 0.69 0.38 79 79 37 9 2.08 (9.08) 2.43
Dec14 2011 2 7 5 250 0.67 0.23 78.8 78.8 37 9.1 2.14 (9.06) 2.51
Dec14 2011 3 7 5 250 0.59 0.31 78.9 78.9 37 9.5 2.2 (9.08) 2.52
Dec14 2011 4 7 5 250 0.62 0.26 78.8 78.8 37 9.5 2.2 (9.08) 2.34
Jan19 2012 1 7 5 200 0.66 0.44 79 79 36.9 7.7 2.2 (9.06) 2.26
Jan19 2012 2 7 5 200 0.54 0.64 78.9 78.9 36.9 7.9 2.27 (9.08) 2.34
Jan19 2012 3 7 5 200 0.62 0.13 78.7 78.7 36.8 10.2 2.27 (9.08) 2.34
4 7 5 200 No Crystal
Jan27 2012 1 7 5 150 0.55 0.62 77.4 77.4 37.1 8.3 2.13 (9.30) 4.65
Jan27 2012 2 7 5 150 0.43 1.04 78.8 78.8 36.9 7.4 N/A
Jan27 2012 3 7 5 150 0.55 0.33 78.8 78.8 36.9 9.9 2.42 (9.05) 2.42
4 7 5 150 TWINNED
Feb2 2012 1 7 5 100 0.71 0.1 78.9 78.9 36.9 9.4
Feb2 2012 2 7 5 100 0.57 0.12 79.2 79.2 37 10.8
Feb14 2012 3 7 5 100 0.58 0.13 78.9 78.9 36.9 10.9
Feb14 2012 4 7 5 100 0.62 0.17 78.9 78.9 36.9 9.8
Feb14 2012 1 7 5 50 0.67 0.14 78.9 78.9 36.9 9.9
Feb14 2012 2 7 5 50 0.64 0.12 78.9 78.9 36.9 10.2
Feb14 2012 3 7 5 50
Feb14 2012 4 7 5 50
Cell Dimensions
Appendix A: AutoProcess results for HEWL
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Date # Energy Time Pressure Anom Signal Anom Signal Ano Corr Notes
Collected (keV) (min) (psi) I/σ(I) Rmrgd Completeness (%) Ano Corr Max Total Total
Nov 29 2011 1 7 Control Control 2.5 1.354 38
Nov 29 2011 2 7 Control Control 2.019 1.008 21
Nov 30 2011 3 7 Control Control 2.085 1.182 32
Nov 30 2011 4 7 Control Control 3.345 1.719 57 *
Mar14 2012 1 7 60 500 43.38 2 100 69 3.66 2.268 75 only frozen 1 hours before collection
Mar14 2012 2 7 60 500 64.95 1.4 100 76 4.153 2.281 70 collected immediately after freezing
Mar14 2012 3 7 60 500 67.12 1.3 100 81 3.893 2.581 78 collected immediately after freezing
Mar14 2012 4 7 60 500 53.47 1.8 99.9 69 3.623 2.241 69
1 7 5 350
Nov 30 2011 2 7 5 350 30.46 3.3 100 53 2.905 1.564 49
Nov 30 2011 3 7 5 350 37.94 2 100 43 2.065 1.054 19 *
Nov 30 2011 4 7 5 350 2.787 1.479 45
Dec14 2011 1 7 5 300 47 2 100 72 3.66 2.098 66  
Dec14 2011 2 7 5 300 67.88 1.4 96.8 77 4.167 2.803 82
Dec14 2011 3 7 5 300 41.39 2.2 97.1 58 2.95 1.804 60
Dec14 2011 4 7 5 300 20.04 7.7 47.8 23 3.271 2.165 70 Structure built first try
Dec14 2011 1 7 5 250 33.17 3.1 100 43 2.77 1.453 48
Dec14 2011 2 7 5 250 39 2.1 100 62 3.166 1.542 47
Dec14 2011 3 7 5 250 32.08 3.1 100 49 2.968 1.432 40
Dec14 2011 4 7 5 250 38.65 2.4 100 48 2.782 1.516 48
Jan19 2012 1 7 5 200 25.57 2.3 100 61 3.799 1.467 71
Jan19 2012 2 7 5 200 24.88 2.2 99.7 62 3.594 1.231 66
Jan19 2012 3 7 5 200 42.43 2.5 99.9 60 3.843 1.975 59
4 7 5 200
Jan27 2012 1 7 5 150 45.61 1.8 99.8 55 2.159 0.841 3
Jan27 2012 2 7 5 150 1.244 0.791 3
Jan27 2012 3 7 5 150 39.92 2.5 96.8 54 2.906 1.543 50
4 7 5 150
Feb2 2012 1 7 5 100 3.667 1.768 52
Feb2 2012 2 7 5 100 2.582 1.133 25
Feb14 2012 3 7 5 100 2.036 1.504 53
Feb14 2012 4 7 5 100 3.79 2.113 67
Feb14 2012 1 7 5 50 3.469 1.679 54
Feb14 2012 2 7 5 50 3.605 1.831 59
Feb14 2012 3 7 5 50
Feb14 2012 4 7 5 50
in highest resolution shell
Appendix A: AutoProcess results for HEWL
Date Puck # # Energy Time Pressure Processing Mosaicity Space Multiplicity Resolution (low) Anomalous
Collected (keV) (min) (psi) Score Group a b c (Å) Cutoff (Å)
GI May 15 2012 1 7 5 500 0.6 0.21 I222 92.7 98.1 102 5 2.27 (9.08) 3.03
THERM Jul5 2012 7 5 300 0.68 0.15 P6122 92.9 92.9 129.7 13.2 2.08 (9.08) 2.27
THERM Oct5 2011 6.5 15 160 0.63 0.14 P622 93 93 129.3 6.4 2.44 (9.76) 2.94
THAU May15 2012 7 5 500 0.61 0.09 P41212 57.8 57.8 150.2 10.6 2.27 (9.09) 2.74
THAU Jul5 2012 7 5 500 0.63 0.09 P41212 57.9 57.9 150.2 11.6 2.27 (9.08) 3.03
THAU Jul5 2012 7 5 300 0.72 0.09 P41212 57.8 57.8 150.2 10.3 2.2 (9.08) 2.27
THAU Sep21 2011 7 15 280 0.41 0.59 P4212 58 58 150.4 3.9 2.34 (9.08) 6.42
THAU Sep21 2011 7 15 200 0.59 0.16 P41212 58 58 150.5 4.7 2.34 (9.08) 4.06
THAU Sep28 2011 1 6.5 15 160 0.58 0.3 P41212 58 58 150.5 3.5 2.3 (9.76) 3.98
THAU Sep28 2011 1 6 15 160 0.59 0.3 P41212 58 58 150.5 3.5 2.49 (10.57) 5.28
THAU Sep28 2011 1 6.5 15 100 0.69 0.14 P41212 57.9 57.9 150 3.2 2.18 (9.76) 4.37
THAU Sep28 2011 1 6 15 100 0.7 0.11 P41212 58 58 150.4 3.2 2.37 (10.6) 3.35
Cell Dimensions
Appendix A: Autoprocess results for other proteins
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Date Puck # # Energy Time Pressure Anom Signal Anom Signal Ano Corr Notes
Collected (keV) (min) (psi) I/σ(I) Rmrgd Completeness (%) Ano Corr Max Total Total
GI May 15 2012 1 7 5 500 28.99 3.8 100 42 2.087 1.133 29
THERM Jul5 2012 7 5 300 24.49 10.8 100 52 3.939 2.153 66
THERM Oct5 2011 6.5 15 160 22.46 5.3 99.5 48 2.616 1.338 39
THAU May15 2012 7 5 500 46.81 2.4 98.3 41 3.061 1.334 34
THAU Jul5 2012 7 5 500 49.2 4.7 98.6 43 2.643 1.235 36
THAU Jul5 2012 7 5 300 58.48 3.4 100 55 3.293 1.688 56
THAU Sep21 2011 7 15 280 22.27 5 99.4 45 1.239 0.82 3
THAU Sep21 2011 7 15 200 58.53 1.3 99.9 48 2.113 1.058 20
THAU Sep28 2011 1 6.5 15 160 49.72 2.1 99.3 28 2.161 1.002 12
THAU Sep28 2011 1 6 15 160 40.92 2.5 99.4 47 2.064 1.043 18
THAU Sep28 2011 1 6.5 15 100 54.65 1.5 100 49 1.88 1.089 22
THAU Sep28 2011 1 6 15 100 40.03 2.7 100 25 2.007 1.146 27
in highest resolution shell
Appendix A: Autoprocess results for other proteins
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Date # Energy Time Pressure
Collected (keV) (min) (psi) # Sites High Resolution Low Resolution # Sites CC
Mar14 2012 1 7 60 500 13 2.19 9.04 13 0.43
Mar14 2012 2 7 60 500 15 2.33 9.03 13 0.39
Mar14 2012 3 7 60 500 20 2.33 9.03 14 0.42
Mar14 2012 4 7 60 500 20 2.26 9.03 17 0.43
1 7 5 350
Nov 30 2011 2 7 5 350 11 2.34 9.08 11 0.37
Nov 30 2011 3 7 5 350 14 3.43 9.08 14 0.41
Nov 30 2011 4 7 5 350 24 2.35 9.08 16 0.36
Dec14 2011 1 7 5 300 25 2.35 9.08 17 0.41
Dec14 2011 2 7 5 300 23 2.34 9.08 18 0.43
Dec14 2011 3 7 5 300 20 2.34 9.08 14 0.38
Dec14 2011 4 7 5 300
Dec14 2011 1 7 5 250 20 2.43 9.08 16 0.37
Dec14 2011 2 7 5 250 19 2.51 9.06 13 0.41
Dec14 2011 3 7 5 250 15 2.52 9.08 9 0.33
Dec14 2011 4 7 5 250 17 2.43 9.08 13 0.42
Jan19 2012 1 7 5 200 13 2.34 9.08 13 0.24
Jan19 2012 2 7 5 200 17 2.34 9.08 15 0.41
Jan19 2012 3 7 5 200 20 2.34 9.08 14 0.38
4 7 5 200
Appendix B: HySS results for lysozyme
Hybrid Substructure Search (HYSS)
Input Output
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Date # Energy Time Pressure # Sites Space Notes
Collected (keV) (min) (psi) # Sites High Resolution Limit Refined Rwork Rfree Model CC FOM Group x y z occ (>0.10)
Mar14 2012 1 7 60 500 13 2.13 20 0.4499 0.4806 0.5 0.447 P43212 0.454 0.718 0.043 0.15
0.691 0.691 0 0.1
20 0.4244 0.4535 0.63 0.447 P43212 0.454 0.718 0.042 0.14 thorough
0.691 0.691 0 0.09
Mar14 2012 2 7 60 500 13 2.13 19 0.4478 0.482 0.52 0.444 P43212 0.453 0.718 0.043 0.13
0.691 0.691 0 0.08
Mar14 2012 3 7 60 500 14 2.26 14 0.495 0.5298 0.43 0.46 P43212 0.046 0.782 0.046 0.17
0.81 0.81 0 0.12
Mar14 2012 4 7 60 500 17 2.19 21 0.449 0.5052 0.5 0.457 P43212 0.453 0.718 0.044 0.16
0.691 0.691 0 0.13
1 7 5 350
Nov 30 2011 2 7 5 350 11 2.14 21 0.4441 0.4734 0.5 0.42 P43212 0.454 0.717 0.046 0.18
0.69 0.69 0 0.11
Nov 30 2011 3 7 5 350 14 2.2 14 0.5592 0.5715 0.11 0.237 P41212 - - - -
Nov 30 2011 4 7 5 350 16 2.35 21 0.5413 0.5604 0.38 0.414 P43212 0.454 0.717 0.046 0.18
0.691 0.691 0 0.12
Dec14 2011 1 7 5 300 17 2.2 22 0.4497 0.4787 0.5 0.452 P43212 0.455 0.717 0.047 0.21
0.691 0.691 0 0.12
Dec14 2011 2 7 5 300 18 2.27 22 0.4735 0.516 0.5 0.468 P43212 0.046 0.783 0.046 0.19
0.809 0.809 0 0.13
Dec14 2011 3 7 5 300 14 2.34 22 0.4921 0.5426 0.45 0.448 P43212 0.046 0.783 0.046 0.17
0.809 0.809 0 0.11
Dec14 2011 4 7 5 300 2 2.03 22 0.28 0.3 0.834 0.44 P43212 0.456 0.717 0.049 0.18 Thorough build, special
0.693 0.693 0 0.14
0.105 0.401 0.454 0.08 All other sites <0.7
Dec14 2011 1 7 5 250 16 2.08 21 0.4725 0.5304 0.47 0.387 P43212 0.046 0.782 0.043 0.16
0.809 0.809 0 0.13
Dec14 2011 2 7 5 250 13 2.14 22 0.4471 0.4516 0.49 0.419 P43212 0.546 0.283 0.045 0.16
0.309 0.309 0 0.13
Dec14 2011 3 7 5 250 9 2.2 17 0.5326 0.5661 0.36 0.385 P43212 0.045 0.782 0.047 0.18
0.809 0.809 0 0.13
Dec14 2011 4 7 5 250 13 2.2 20 0.4681 0.49 0.47 0.414 P43212 0.453 0.717 0.045 0.13
0.691 0.691 0 0.09
Jan19 2012 1 7 5 200 13 2.27 19 0.5209 0.547 0.37 0.42 P43212 0.283 0.544 0.047 0.23
0.308 0.308 0 0.11
Jan19 2012 2 7 5 200 15 2.27 14 0.5776 0.5937 0.26 0.236 P43212 - - - -
Jan19 2012 3 7 5 200 14 2.27 20 0.4964 0.5325 0.43 0.416 P43212 0.454 0.717 0.046 0.14
0.69 0.69 0 0.11
4 7 5 200
Xenon Sites (fractional)
AutoSol
Input Output
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Date # Energy Time Pressure
Collected (keV) (min) (psi) # Sites High Resolution Low Resolution # Sites CC
Jan27 2012 1 7 5 150 19 4.65 9.3 19 0.67
Jan27 2012 2 7 5 150 N/A
Jan27 2012 3 7 5 150 7 2.42 9.05 7 0.18
4 7 5 150 N/A
Feb2 2012 1 7 5 100
Feb2 2012 2 7 5 100
Feb14 2012 3 7 5 100
Feb14 2012 4 7 5 100
Feb14 2012 1 7 5 50
Feb14 2012 2 7 5 50
Feb14 2012 3 7 5 50
Feb14 2012 4 7 5 50
Nov 29 2011 1 7 Control Control
Nov 29 2011 2 7 Control Control
Nov 30 2011 3 7 Control Control
Nov 30 2011 4 7 Control Control
Appendix B: Hyss results for lysozyme
Hybrid Substructure Search (HYSS)
Input Output
Appendix B: AutoSol results for lysozyme
Date # Energy Time Pressure # Sites Space Notes
Collected (keV) (min) (psi) # Sites High Resolution Limit Refined Rwork Rfree Model CC FOM Group x y z occ (>0.10)
Jan27 2012 1 7 5 150 19 2.13 17 0.5859 0.5979 0.08 0.216 P41212 - - - - Fast build
0.5745 0.557 0.22 0.216 P41212 - - - - Thorough build
Jan27 2012 2 7 5 150
Jan27 2012 3 7 5 150 7 2.42 7 0.6184 0.6208 0.24 0.209 P4212 - - - -
4 7 5 150
Feb2 2012 1 7 5 100
Feb2 2012 2 7 5 100
Feb14 2012 3 7 5 100
Feb14 2012 4 7 5 100
Feb14 2012 1 7 5 50
Feb14 2012 2 7 5 50
Feb14 2012 3 7 5 50
Feb14 2012 4 7 5 50
Nov 29 2011 1 7 Control Control
Nov 29 2011 2 7 Control Control
Nov 30 2011 3 7 Control Control
Nov 30 2011 4 7 Control Control
Xenon Sites (fractional)
AutoSol
Input Output
98 
 
 
D
ate
P
u
ck #
#
En
e
rgy
Tim
e
P
re
ssu
re
# Site
s
Sp
ace
C
o
lle
cte
d
(ke
V
)
(m
in
)
(p
si)
# Site
s
H
igh
 R
e
so
lu
tio
n
Lo
w
 R
e
so
lu
tio
n
# Site
s
C
C
# Site
s
H
igh
 R
e
so
lu
tio
n
 Lim
it
R
e
fin
e
d
R
w
o
rk
R
fre
e
M
o
d
e
l C
C
FO
M
G
ro
u
p
x
y
z
o
cc (>0.10)
G
I
M
ay 15 2012
1
7
5
500
19
3.03
9.08
14
0.4
14
2.27
11
0.4035
0.4259
0.55
0.371
I222
-0.428
0.271
-0.357
0.59
M
agn
e
siu
m
??
TH
ER
M
Ju
l5 2012
7
5
300
9
2.27
9.08
9
0.55
9
2.08
8
0.3999
0.443
0.58
0.475
P
6122
-0.042
-0.347
-0.625
0.8
TH
ER
M
O
ct 5 2011
6.5
15
160
20
2.94
9.76
17
0.26
17
2.44
14
0.5416
0.5342
0.28
0.424
P
622
0
0
0
2.36
TH
A
U
M
ay15 2012
7
5
500
19
2.74
9.09
9
0.41
9
2.27
17
0.433
0.4606
0.56
0.337
P
41212
-0.07
-0.219
-0.052
0.1
TH
A
U
Ju
l5 2012
7
5
500
14
3.03
9.08
9
0.32
9
2.27
18
0.4372
0.4606
0.51
0.338
P
41212
-0.07
-0.22
-0.051
0.1
TH
A
U
Ju
l5 2012
7
5
300
13
2.27
9.08
10
0.27
10
2.2
21
0.4183
0.4516
0.55
0.429
P
41212
-0.076
-0.219
-0.057
0.13
TH
A
U
Se
p
21 2011
7
15
280
13
6.42
9.08
9
0.59
9
2.34
7
-
-
-
0.158
P
4212
-
-
-
-
TH
A
U
Se
p
21 2011
7
15
200
9
4.06
9.08
9
0.33
9
2.34
8
0.5738
0.5623
0.19
0.172
P
43212
-
-
-
-
TH
A
U
Se
p
28 2011
1
6.5
15
160
19
3.98
9.76
19
0.44
19
2.3
17
0.5879
0.5805
0.12
0.201
P
43212
-
-
-
-
TH
A
U
Se
p
28 2011
1
6
15
160
16
5.28
10.57
16
0.52
16
2.49
15
0.5659
0.5657
0.07
0.2
P
41212
-
-
-
-
TH
A
U
Se
p
28 2011
1
6.5
15
100
14
4.37
9.76
14
0.42
14
2.18
14
0.5668
0.5857
0.09
0.175
P
41212
-
-
-
-
TH
A
U
Se
p
28 2011
1
6
15
100
24
3.35
10.6
16
0.27
16
2.37
16
0.5637
0.5808
0.14
0.201
P
43212
0.147
0.166
0.105
0.13
A
p
p
e
n
d
ix B
: H
ySS &
 A
u
to
so
l re
su
lts fo
r o
th
e
r p
ro
te
in
s
X
e
n
o
n
 Site
s (fractio
n
al)
H
yb
rid
 Su
b
stru
ctu
re
 Se
arch
 (H
YSS)
A
u
to
So
l
In
p
u
t
O
u
tp
u
t
In
p
u
t
O
u
tp
u
t
